{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:16:02Z","timestamp":1794975362657,"version":"4.9.1"},"reference-count":303,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Excellent Youth Talent Cultivation Program of Innovation in Health Science and Technology of Henan Province","award":["YXKC2022061"],"award-info":[{"award-number":["YXKC2022061"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M752952"],"award-info":[{"award-number":["2024M752952"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Henan Medical Science and Technology Joint Building Program","award":["LHGJ20230239"],"award-info":[{"award-number":["LHGJ20230239"]}]},{"DOI":"10.13039\/501100001809","name":"China National Natural Science Foundation","doi-asserted-by":"crossref","award":["82102149, 82472069, and 82401623"],"award-info":[{"award-number":["82102149, 82472069, and 82401623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-024-02164-y","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T09:27:33Z","timestamp":1730280453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":208,"title":["Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henan","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2164_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms242216304","volume":"24","author":"I Sadok","year":"2023","unstructured":"Sadok I, J\u0119druchniewicz K. Dietary kynurenine pathway metabolites-source, fate, and chromatographic determinations. Int J Mol Sci. 2023;24:24. https:\/\/doi.org\/10.3390\/ijms242216304.","journal-title":"Int J Mol Sci."},{"key":"2164_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23116300","volume":"23","author":"L Jamshed","year":"2022","unstructured":"Jamshed L, Debnath A, Jamshed S, Wish JV, Raine JC, Tomy GT, et al. An emerging cross-species marker for organismal health: tryptophan-kynurenine pathway. Int J Mol Sci. 2022;23:23. https:\/\/doi.org\/10.3390\/ijms23116300.","journal-title":"Int J Mol Sci."},{"key":"2164_CR3","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1039\/c5fo00407a","volume":"6","author":"AB Nongonierma","year":"2015","unstructured":"Nongonierma AB, FitzGerald RJ. Milk proteins as a source of tryptophan-containing bioactive peptides. Food Funct. 2015;6:2115\u201327. https:\/\/doi.org\/10.1039\/c5fo00407a.","journal-title":"Food Funct"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1017\/s0033291703008547","volume":"33","author":"MJ Attenburrow","year":"2003","unstructured":"Attenburrow MJ, Williams C, Odontiadis J, Powell J, Van de Ouderaa F, Williams M, et al. The effect of a nutritional source of tryptophan on dieting-induced changes in brain 5-HT function. Psychol Med. 2003;33:1381\u20136. https:\/\/doi.org\/10.1017\/s0033291703008547.","journal-title":"Psychol Med"},{"key":"2164_CR5","doi-asserted-by":"publisher","unstructured":"Wyatt M, Greathouse KL. Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer. Nutrients. 2021;13. https:\/\/doi.org\/10.3390\/nu13041189.","DOI":"10.3390\/nu13041189"},{"key":"2164_CR6","doi-asserted-by":"publisher","unstructured":"Melhem NJ, Taleb S. Tryptophan: from diet to cardiovascular diseases. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22189904.","DOI":"10.3390\/ijms22189904"},{"key":"2164_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24065742","volume":"24","author":"A Tsuji","year":"2023","unstructured":"Tsuji A, Ikeda Y, Yoshikawa S, Taniguchi K, Sawamura H, Morikawa S, et al. The tryptophan and kynurenine pathway involved in the development of immune-related diseases. Int J Mol Sci. 2023;24:24. https:\/\/doi.org\/10.3390\/ijms24065742.","journal-title":"Int J Mol Sci."},{"key":"2164_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00726-010-0752-7","volume":"41","author":"N Le Floc\u2019h","year":"2011","unstructured":"Le Floc\u2019h N, Otten W, Merlot E. Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids. 2011;41:1195\u2013205. https:\/\/doi.org\/10.1007\/s00726-010-0752-7.","journal-title":"Amino Acids"},{"key":"2164_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1179\/135100099101534927","volume":"4","author":"SR Thomas","year":"1999","unstructured":"Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep. 1999;4:199\u2013220. https:\/\/doi.org\/10.1179\/135100099101534927.","journal-title":"Redox Rep"},{"key":"2164_CR10","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1113\/jp284142","volume":"601","author":"JM Hinkley","year":"2023","unstructured":"Hinkley JM, Yu GX, Standley RA, Distefano G, Tolstikov V, Narain NR, et al. Exercise and ageing impact the kynurenine\/tryptophan pathway and acylcarnitine metabolite pools in skeletal muscle of older adults. J Physiol. 2023;601:2165\u201388. https:\/\/doi.org\/10.1113\/jp284142.","journal-title":"J Physiol"},{"key":"2164_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1042\/cs20160153","volume":"130","author":"AA Badawy","year":"2016","unstructured":"Badawy AA, Namboodiri AM, Moffett JR. The end of the road for the tryptophan depletion concept in pregnancy and infection. Clin Sci (Lond). 2016;130:1327\u201333. https:\/\/doi.org\/10.1042\/cs20160153.","journal-title":"Clin Sci (Lond)"},{"key":"2164_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109840","volume":"117","author":"W Lai","year":"2023","unstructured":"Lai W, Huang Z, Li S, Li XG, Luo D. Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response. Int Immunopharmacol. 2023;117: 109840. https:\/\/doi.org\/10.1016\/j.intimp.2023.109840.","journal-title":"Int Immunopharmacol"},{"key":"2164_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/jnnp.33.5.698","volume":"33","author":"G Curzon","year":"1970","unstructured":"Curzon G, Bridges PK. Tryptophan metabolism in depression. J Neurol Neurosurg Psychiatry. 1970;33:698\u2013704. https:\/\/doi.org\/10.1136\/jnnp.33.5.698.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2164_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.molmed.2013.02.007","volume":"19","author":"AT van der Goot","year":"2013","unstructured":"van der Goot AT, Nollen EA. Tryptophan metabolism: entering the field of aging and age-related pathologies. Trends Mol Med. 2013;19:336\u201344. https:\/\/doi.org\/10.1016\/j.molmed.2013.02.007.","journal-title":"Trends Mol Med"},{"key":"2164_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/ijms21186670","volume":"21","author":"JM Anaya","year":"2020","unstructured":"Anaya JM, Bollag WB, Hamrick MW, Isales CM. The role of tryptophan metabolites in musculoskeletal stem cell aging. Int J Mol Sci. 2020;21:21. https:\/\/doi.org\/10.3390\/ijms21186670.","journal-title":"Int J Mol Sci."},{"key":"2164_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/nmo.13283","volume":"30","author":"JJ Galligan","year":"2018","unstructured":"Galligan JJ. Beneficial actions of microbiota-derived tryptophan metabolites. Neurogastroenterol Motil. 2018;30:30. https:\/\/doi.org\/10.1111\/nmo.13283.","journal-title":"Neurogastroenterol Motil."},{"key":"2164_CR17","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1073\/pnas.87.7.2506","volume":"87","author":"S Christen","year":"1990","unstructured":"Christen S, Peterhans E, Stocker R. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci U S A. 1990;87:2506\u201310. https:\/\/doi.org\/10.1073\/pnas.87.7.2506.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.semcdb.2015.03.002","volume":"40","author":"DC Maddison","year":"2015","unstructured":"Maddison DC, Giorgini F. The kynurenine pathway and neurodegenerative disease. Semin Cell Dev Biol. 2015;40:134\u201341. https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.002.","journal-title":"Semin Cell Dev Biol"},{"key":"2164_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.immuni.2022.05.013","volume":"55","author":"M Gargaro","year":"2022","unstructured":"Gargaro M, Scalisi G, Manni G, Brise\u00f1o CG, Bagadia P, Durai V, et al. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication. Immunity. 2022;55:1032\u201350.","journal-title":"Immunity"},{"key":"2164_CR20","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1021\/acs.jafc.1c04145","volume":"70","author":"JE Koper","year":"2022","unstructured":"Koper JE, Troise AD, Loonen LM, Vitaglione P, Capuano E, Fogliano V, et al. Tryptophan supplementation increases the production of microbial-derived AhR agonists in an in vitro simulator of intestinal microbial ecosystem. J Agric Food Chem. 2022;70:3958\u201368. https:\/\/doi.org\/10.1021\/acs.jafc.1c04145.","journal-title":"J Agric Food Chem"},{"key":"2164_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116714","volume":"317","author":"X Liang","year":"2023","unstructured":"Liang X, Su T, Wu P, Dai Y, Chen Y, Wang Q, et al. Identification of paeoniflorin from Paeonia lactiflora pall. As an inhibitor of tryptophan 2,3-dioxygenase and assessment of its pharmacological effects on depressive mice. J Ethnopharmacol. 2023;317: 116714. https:\/\/doi.org\/10.1016\/j.jep.2023.116714.","journal-title":"J Ethnopharmacol"},{"key":"2164_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41398-022-01992-0","volume":"12","author":"R Raghavan","year":"2022","unstructured":"Raghavan R, Anand NS, Wang G, Hong X, Pearson C, Zuckerman B, et al. Association between cord blood metabolites in tryptophan pathway and childhood risk of autism spectrum disorder and attention-deficit hyperactivity disorder. Transl Psychiatry. 2022;12:270. https:\/\/doi.org\/10.1038\/s41398-022-01992-0.","journal-title":"Transl Psychiatry"},{"key":"2164_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/nutrit\/nuab027","volume":"80","author":"CN Sutanto","year":"2022","unstructured":"Sutanto CN, Loh WW, Kim JE. The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutr Rev. 2022;80:306\u201316. https:\/\/doi.org\/10.1093\/nutrit\/nuab027.","journal-title":"Nutr Rev"},{"key":"2164_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12906","volume":"75","author":"DJ Kennaway","year":"2023","unstructured":"Kennaway DJ. The mammalian gastro-intestinal tract is a NOT a major extra-pineal source of melatonin. J Pineal Res. 2023;75:e12906. https:\/\/doi.org\/10.1111\/jpi.12906.","journal-title":"J Pineal Res"},{"key":"2164_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/nu14163270","volume":"14","author":"H Liaqat","year":"2022","unstructured":"Liaqat H, Parveen A, Kim SY. Neuroprotective natural products\u2019 regulatory effects on depression via gut-brain axis targeting tryptophan. Nutrients. 2022;14:14. https:\/\/doi.org\/10.3390\/nu14163270.","journal-title":"Nutrients."},{"key":"2164_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crfs.2024.100754","volume":"8","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Yin L, Liu Q, Guan Y, Nie S, Zhu Y, et al. Tryptophan metabolic pathway plays a key role in the stress-induced emotional eating. Curr Res Food Sci. 2024;8: 100754. https:\/\/doi.org\/10.1016\/j.crfs.2024.100754.","journal-title":"Curr Res Food Sci"},{"key":"2164_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone TW, Williams RO. Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends Pharmacol Sci. 2023;44:442\u201356. https:\/\/doi.org\/10.1016\/j.tips.2023.04.006.","journal-title":"Trends Pharmacol Sci"},{"key":"2164_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094644","volume":"22","author":"M Gargaro","year":"2021","unstructured":"Gargaro M, Manni G, Scalisi G, Puccetti P, Fallarino F. Tryptophan metabolites at the crossroad of immune-cell interaction via the Aryl hydrocarbon receptor: implications for tumor immunotherapy. Int J Mol Sci. 2021;22:22. https:\/\/doi.org\/10.3390\/ijms22094644.","journal-title":"Int J Mol Sci."},{"key":"2164_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01497","volume":"11","author":"J G\u00fcnther","year":"2020","unstructured":"G\u00fcnther J, Fallarino F, Fuchs D, Wirthgen E, Editorial. Immunomodulatory roles of tryptophan metabolites in inflammation and cancer. Front Immunol. 2020;11: 1497. https:\/\/doi.org\/10.3389\/fimmu.2020.01497.","journal-title":"Front Immunol"},{"key":"2164_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25020853","volume":"25","author":"S Pathak","year":"2024","unstructured":"Pathak S, Nadar R, Kim S, Liu K, Govindarajulu M, Cook P, et al. The influence of kynurenine metabolites on neurodegenerative pathologies. Int J Mol Sci. 2024;25:25. https:\/\/doi.org\/10.3390\/ijms25020853.","journal-title":"Int J Mol Sci."},{"key":"2164_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/acel.14102","volume":"23","author":"MM Gabrawy","year":"2024","unstructured":"Gabrawy MM, Westbrook R, King A, Khosravian N, Ochaney N, DeCarvalho T, et al. Dual treatment with kynurenine pathway inhibitors and NAD(+) precursors synergistically extends life span in Drosophila. Aging Cell. 2024;23: e14102. https:\/\/doi.org\/10.1111\/acel.14102.","journal-title":"Aging Cell"},{"key":"2164_CR32","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.molmed.2021.07.006","volume":"27","author":"N Joisten","year":"2021","unstructured":"Joisten N, Ruas JL, Braidy N, Guillemin GJ, Zimmer P. The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force? Trends Mol Med. 2021;27:946\u201354. https:\/\/doi.org\/10.1016\/j.molmed.2021.07.006.","journal-title":"Trends Mol Med"},{"key":"2164_CR33","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.cell.2023.03.022","volume":"186","author":"MS Pereira","year":"2023","unstructured":"Pereira MS, Kriegel MA. Translocating lactobacillus torments tumors via tryptophan catabolism. Cell. 2023;186:1821\u20133. https:\/\/doi.org\/10.1016\/j.cell.2023.03.022.","journal-title":"Cell"},{"key":"2164_CR34","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112963","volume":"42","author":"L Wojciech","year":"2023","unstructured":"Wojciech L, Png CW, Koh EY, Kioh DYQ, Deng L, Wang Z, et al. A tryptophan metabolite made by a gut microbiome eukaryote induces pro-inflammatory T cells. Embo j. 2023;42: e112963. https:\/\/doi.org\/10.15252\/embj.2022112963.","journal-title":"Embo j"},{"key":"2164_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","volume":"71","author":"J Huang","year":"2022","unstructured":"Huang J, Liu D, Wang Y, Liu L, Li J, Yuan J, et al. Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy. Gut. 2022;71:734\u201345. https:\/\/doi.org\/10.1136\/gutjnl-2020-321031.","journal-title":"Gut"},{"key":"2164_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104892","volume":"98","author":"J Wei","year":"2023","unstructured":"Wei J, Yang Z, Li J, Zhang Y, Zhang W, Doherty M, et al. Association between gut microbiome-related metabolites and symptomatic hand osteoarthritis in two independent cohorts. EBioMedicine. 2023;98: 104892. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104892.","journal-title":"EBioMedicine"},{"key":"2164_CR37","doi-asserted-by":"publisher","unstructured":"Madella AM, Van Bergenhenegouwen J, Garssen J, Masereeuw R, Overbeek SA. Microbial-derived tryptophan catabolites, kidney disease and gut inflammation. Toxins (Basel). 2022;14. https:\/\/doi.org\/10.3390\/toxins14090645.","DOI":"10.3390\/toxins14090645"},{"key":"2164_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu15143132","volume":"15","author":"J Ballesteros","year":"2023","unstructured":"Ballesteros J, Rivas D, Duque G. The role of the kynurenine pathway in the pathophysiology of frailty, sarcopenia, and osteoporosis. Nutrients. 2023;15:15. https:\/\/doi.org\/10.3390\/nu15143132.","journal-title":"Nutrients."},{"key":"2164_CR39","doi-asserted-by":"publisher","first-page":"10571","DOI":"10.1021\/jacs.6b05578","volume":"138","author":"JW Meisel","year":"2016","unstructured":"Meisel JW, Patel MB, Garrad E, Stanton RA, Gokel GW. Reversal of tetracycline resistance in Escherichia coli by Noncytotoxic bis(Tryptophan)s. J Am Chem Soc. 2016;138:10571\u20137. https:\/\/doi.org\/10.1021\/jacs.6b05578.","journal-title":"J Am Chem Soc"},{"key":"2164_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094523","volume":"22","author":"YH Ahn","year":"2021","unstructured":"Ahn YH, Oh SC, Zhou S, Kim TD. Tryptophanyl-tRNA synthetase as a potential therapeutic target. Int J Mol Sci. 2021;22:22. https:\/\/doi.org\/10.3390\/ijms22094523.","journal-title":"Int J Mol Sci."},{"key":"2164_CR41","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/0008-5472.Can-12-0569","volume":"72","author":"M Platten","year":"2012","unstructured":"Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72:5435\u201340. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0569.","journal-title":"Cancer Res"},{"key":"2164_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41419-023-05616-3","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang N, Xu L, Liu Y, Huang L, Gu M, et al. Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia\/reperfusion injury. Cell Death Dis. 2023;14:92. https:\/\/doi.org\/10.1038\/s41419-023-05616-3.","journal-title":"Cell Death Dis"},{"key":"2164_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104827","volume":"299","author":"L Zeitler","year":"2023","unstructured":"Zeitler L, Murray PJ. IL4i1 and IDO1: oxidases that control a tryptophan metabolic nexus in cancer. J Biol Chem. 2023;299: 104827. https:\/\/doi.org\/10.1016\/j.jbc.2023.104827.","journal-title":"J Biol Chem"},{"key":"2164_CR44","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1002\/mco2.559","volume":"5","author":"G Li","year":"2024","unstructured":"Li G, Yao Q, Liu P, Zhang H, Liu Y, Li S, et al. Critical roles and clinical perspectives of RNA methylation in cancer. MedComm (2020). 2024;5:e559. https:\/\/doi.org\/10.1002\/mco2.559.","journal-title":"MedComm (2020)"},{"key":"2164_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13046-021-01971-1","volume":"40","author":"D Ye","year":"2021","unstructured":"Ye D, Xu H, Xia H, Zhang C, Tang Q, Bi F. Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment. J Exp Clin Cancer Res. 2021;40:173. https:\/\/doi.org\/10.1186\/s13046-021-01971-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"2164_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-024-01552-7","volume":"22","author":"L Yu","year":"2024","unstructured":"Yu L, Lu J, Du W. Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications. Cell Commun Signal. 2024;22:174. https:\/\/doi.org\/10.1186\/s12964-024-01552-7.","journal-title":"Cell Commun Signal"},{"key":"2164_CR47","doi-asserted-by":"publisher","first-page":"115804","DOI":"10.1016\/j.bcp.2023.115804","volume":"217","author":"JHL Pacheco","year":"2023","unstructured":"Pacheco JHL, Elizondo G. Interplay between Estrogen, Kynurenine, and AHR pathways: an immunosuppressive axis with therapeutic potential for breast cancer treatment. Biochem Pharmacol. 2023;217:115804. https:\/\/doi.org\/10.1016\/j.bcp.2023.115804.","journal-title":"Biochem Pharmacol"},{"key":"2164_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094403","volume":"22","author":"M Mandarano","year":"2021","unstructured":"Mandarano M, Orecchini E, Bellezza G, Vannucci J, Ludovini V, Baglivo S, et al. Kynurenine\/Tryptophan ratio as a potential blood-based biomarker in non-small cell lung cancer. Int J Mol Sci. 2021;22:22. https:\/\/doi.org\/10.3390\/ijms22094403.","journal-title":"Int J Mol Sci."},{"key":"2164_CR49","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1186\/s12885-021-08855-9","volume":"21","author":"F Li","year":"2021","unstructured":"Li F, Zhao Z, Zhang Z, Zhang Y, Guan W. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR\/c-Myc dependent manner. BMC Cancer. 2021;21:1112. https:\/\/doi.org\/10.1186\/s12885-021-08855-9.","journal-title":"BMC Cancer"},{"key":"2164_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00249","volume":"11","author":"L Lanser","year":"2020","unstructured":"Lanser L, Kink P, Egger EM, Willenbacher W, Fuchs D, Weiss G, et al. Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer. Front Immunol. 2020;11: 249. https:\/\/doi.org\/10.3389\/fimmu.2020.00249.","journal-title":"Front Immunol"},{"key":"2164_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.636081","volume":"12","author":"M Kim","year":"2021","unstructured":"Kim M, Tomek P, Tryptophan. A rheostat of cancer immune escape mediated by immunosuppressive enzymes IDO1 and TDO. Front Immunol. 2021;12: 636081. https:\/\/doi.org\/10.3389\/fimmu.2021.636081.","journal-title":"Front Immunol"},{"key":"2164_CR52","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1158\/1078-0432.Ccr-15-0420","volume":"21","author":"L Zhai","year":"2015","unstructured":"Zhai L, Spranger S, Binder DC, Gritsina G, Lauing KL, Giles FJ, et al. Molecular pathways: targeting IDO1 and other tryptophan dioxygenases for cancer immunotherapy. Clin Cancer Res. 2015;21:5427\u201333. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-0420.","journal-title":"Clin Cancer Res"},{"key":"2164_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med. 2022;20:347. https:\/\/doi.org\/10.1186\/s12967-022-03554-w.","journal-title":"J Transl Med"},{"key":"2164_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807271","volume":"13","author":"F Peyraud","year":"2022","unstructured":"Peyraud F, Guegan JP, Bodet D, Cousin S, Bessede A, Italiano A. Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives. Front Immunol. 2022;13: 807271. https:\/\/doi.org\/10.3389\/fimmu.2022.807271.","journal-title":"Front Immunol"},{"key":"2164_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","volume":"122","author":"CA Opitz","year":"2020","unstructured":"Opitz CA, Somarribas Patterson LF, Mohapatra SR, Dewi DL, Sadik A, Platten M, et al. The therapeutic potential of targeting tryptophan catabolism in cancer. Br J Cancer. 2020;122:30\u201344. https:\/\/doi.org\/10.1038\/s41416-019-0664-6.","journal-title":"Br J Cancer"},{"key":"2164_CR56","doi-asserted-by":"publisher","DOI":"10.4161\/2162402x.2014.982382","volume":"4","author":"I Chevolet","year":"2015","unstructured":"Chevolet I, Speeckaert R, Schreuer M, Neyns B, Krysko O, Bachert C, et al. Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma. Oncoimmunology. 2015;4: e982382. https:\/\/doi.org\/10.4161\/2162402x.2014.982382.","journal-title":"Oncoimmunology"},{"key":"2164_CR57","doi-asserted-by":"publisher","first-page":"124924","DOI":"10.1016\/j.foodchem.2019.05.198","volume":"297","author":"M Antonia \u00c1lvarez-Fern\u00e1ndez","year":"2019","unstructured":"Antonia \u00c1lvarez-Fern\u00e1ndez M, Fern\u00e1ndez-Cruz E, Valero E, Troncoso AM, Carmen Garc\u00eda-Parrilla M. Efficiency of three intracellular extraction methods in the determination of metabolites related to tryptophan and tyrosine in winemaking yeast\u2019s metabolism by LC-HRMS. Food Chem. 2019;297:124924. https:\/\/doi.org\/10.1016\/j.foodchem.2019.05.198.","journal-title":"Food Chem"},{"key":"2164_CR58","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/0024-3205(83)90187-x","volume":"32","author":"AH Meier","year":"1983","unstructured":"Meier AH, Wilson JM. Tryptophan feeding adversely influences pregnancy. Life Sci. 1983;32:1193\u20136. https:\/\/doi.org\/10.1016\/0024-3205(83)90187-x.","journal-title":"Life Sci"},{"key":"2164_CR59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuint.2012.12.014","volume":"62","author":"F Shabbir","year":"2013","unstructured":"Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E, et al. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int. 2013;62:324\u20139. https:\/\/doi.org\/10.1016\/j.neuint.2012.12.014.","journal-title":"Neurochem Int"},{"key":"2164_CR60","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","volume":"55","author":"SK Seo","year":"2023","unstructured":"Seo SK, Kwon B. Immune regulation through tryptophan metabolism. Exp Mol Med. 2023;55:1371\u20139. https:\/\/doi.org\/10.1038\/s12276-023-01028-7.","journal-title":"Exp Mol Med"},{"key":"2164_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","volume":"34","author":"TW Stone","year":"2013","unstructured":"Stone TW, Stoy N, Darlington LG. An expanding range of targets for kynurenine metabolites of tryptophan. Trends Pharmacol Sci. 2013;34:136\u201343. https:\/\/doi.org\/10.1016\/j.tips.2012.09.006.","journal-title":"Trends Pharmacol Sci"},{"key":"2164_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.653208","volume":"12","author":"HM Grifka-Walk","year":"2021","unstructured":"Grifka-Walk HM, Jenkins BR, Kominsky DJ. Amino acid trp: the far out impacts of host and commensal tryptophan metabolism. Front Immunol. 2021;12: 653208. https:\/\/doi.org\/10.3389\/fimmu.2021.653208.","journal-title":"Front Immunol"},{"key":"2164_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100575","volume":"296","author":"JC Granados","year":"2021","unstructured":"Granados JC, Richelle A, Gutierrez JM, Zhang P, Zhang X, Bhatnagar V, et al. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3. J Biol Chem. 2021;296: 100575. https:\/\/doi.org\/10.1016\/j.jbc.2021.100575.","journal-title":"J Biol Chem"},{"key":"2164_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coi.2021.03.005","volume":"70","author":"M Platten","year":"2021","unstructured":"Platten M, Friedrich M, Wainwright DA, Panitz V, Opitz CA. Tryptophan metabolism in brain tumors - IDO and beyond. Curr Opin Immunol. 2021;70:57\u201366. https:\/\/doi.org\/10.1016\/j.coi.2021.03.005.","journal-title":"Curr Opin Immunol"},{"key":"2164_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202000461","volume":"65","author":"X Li","year":"2021","unstructured":"Li X, Zhang ZH, Zabed HM, Yun J, Zhang G, Qi X. An insight into the roles of dietary tryptophan and its metabolites in intestinal inflammation and inflammatory bowel disease. Mol Nutr Food Res. 2021;65: e2000461. https:\/\/doi.org\/10.1002\/mnfr.202000461.","journal-title":"Mol Nutr Food Res"},{"key":"2164_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2958.1997.5541915.x","volume":"26","author":"P Babitzke","year":"1997","unstructured":"Babitzke P. Regulation of tryptophan biosynthesis: Trp-ing the TRAP or how Bacillus subtilis reinvented the wheel. Mol Microbiol. 1997;26:1\u20139. https:\/\/doi.org\/10.1046\/j.1365-2958.1997.5541915.x.","journal-title":"Mol Microbiol"},{"key":"2164_CR67","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.molcel.2022.02.007","volume":"82","author":"A Fiore","year":"2022","unstructured":"Fiore A, Zeitler L, Russier M, Gro\u00df A, Hiller MK, Parker JL, et al. Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling. Mol Cell. 2022;82:920\u201332. https:\/\/doi.org\/10.1016\/j.molcel.2022.02.007. .e7.","journal-title":"Mol Cell"},{"key":"2164_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202100092","volume":"65","author":"Z Huang","year":"2021","unstructured":"Huang Z, Schoones T, Wells JM, Fogliano V, Capuano E. Substrate-driven differences in tryptophan catabolism by gut microbiota and aryl hydrocarbon receptor activation. Mol Nutr Food Res. 2021;65: e2100092. https:\/\/doi.org\/10.1002\/mnfr.202100092.","journal-title":"Mol Nutr Food Res"},{"key":"2164_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms231911281","volume":"23","author":"Z Lv","year":"2022","unstructured":"Lv Z, Shi W, Zhang Q. Role of essential amino acids in age-induced bone loss. Int J Mol Sci. 2022;23:23. https:\/\/doi.org\/10.3390\/ijms231911281.","journal-title":"Int J Mol Sci."},{"key":"2164_CR70","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22062973","volume":"22","author":"W Roth","year":"2021","unstructured":"Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M. Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci. 2021;22:22. https:\/\/doi.org\/10.3390\/ijms22062973.","journal-title":"Int J Mol Sci."},{"key":"2164_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-023-01570-9","volume":"24","author":"B Tuka","year":"2023","unstructured":"Tuka B, K\u00f6rt\u00e9si T, N\u00e1n\u00e1si N, T\u00f6m\u00f6si F, Jan\u00e1ky T, Ver\u00e9b D, et al. Cluster headache and kynurenines. J Headache Pain. 2023;24:35. https:\/\/doi.org\/10.1186\/s10194-023-01570-9.","journal-title":"J Headache Pain"},{"key":"2164_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms23179968","volume":"23","author":"M Davidson","year":"2022","unstructured":"Davidson M, Rashidi N, Nurgali K, Apostolopoulos V. The role of tryptophan metabolites in neuropsychiatric disorders. Int J Mol Sci. 2022;23:23. https:\/\/doi.org\/10.3390\/ijms23179968.","journal-title":"Int J Mol Sci."},{"key":"2164_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41392-022-01127-3","volume":"7","author":"F Liang","year":"2022","unstructured":"Liang F, Wang GZ, Wang Y, Yang YN, Wen ZS, Chen DN, et al. Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1. Signal Transduct Target Ther. 2022;7:311. https:\/\/doi.org\/10.1038\/s41392-022-01127-3.","journal-title":"Signal Transduct Target Ther"},{"key":"2164_CR74","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1007\/s12035-016-0004-2","volume":"54","author":"G Morris","year":"2017","unstructured":"Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, et al. The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Mol Neurobiol. 2017;54:4432\u201351. https:\/\/doi.org\/10.1007\/s12035-016-0004-2.","journal-title":"Mol Neurobiol"},{"key":"2164_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.590532","volume":"12","author":"SR Mohapatra","year":"2021","unstructured":"Mohapatra SR, Sadik A, Sharma S, Poschet G, Gegner HM, Lanz TV, et al. Hypoxia routes tryptophan homeostasis towards increased tryptamine production. Front Immunol. 2021;12: 590532. https:\/\/doi.org\/10.3389\/fimmu.2021.590532.","journal-title":"Front Immunol"},{"key":"2164_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110145","volume":"106","author":"M Wi\u0119d\u0142ocha","year":"2021","unstructured":"Wi\u0119d\u0142ocha M, Marcinowicz P, Janoska-Ja\u017adzik M, Szulc A. Gut microbiota, kynurenine pathway and mental disorders - Review. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106: 110145. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110145.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2164_CR77","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2016.07.002","volume":"112","author":"PJ Kennedy","year":"2017","unstructured":"Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology. 2017;112:399\u2013412. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.002.","journal-title":"Neuropharmacology"},{"key":"2164_CR78","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.coi.2020.12.004","volume":"70","author":"T Zelante","year":"2021","unstructured":"Zelante T, Puccetti M, Giovagnoli S, Romani L. Regulation of host physiology and immunity by microbial indole-3-aldehyde. Curr Opin Immunol. 2021;70:27\u201332. https:\/\/doi.org\/10.1016\/j.coi.2020.12.004.","journal-title":"Curr Opin Immunol"},{"key":"2164_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126987","volume":"253","author":"Z He","year":"2023","unstructured":"He Z, Guo J, Zhang H, Yu J, Zhou Y, Wang Y, et al. Atractylodes macrocephala Koidz polysaccharide improves glycolipid metabolism disorders through activation of aryl hydrocarbon receptor by gut flora-produced tryptophan metabolites. Int J Biol Macromol. 2023;253: 126987. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126987.","journal-title":"Int J Biol Macromol"},{"key":"2164_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","volume":"112","author":"MD Lovelace","year":"2017","unstructured":"Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology. 2017;112:373\u201388. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.024.","journal-title":"Neuropharmacology"},{"key":"2164_CR81","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/med.21752","volume":"41","author":"J Zhang","year":"2021","unstructured":"Zhang J, Zhu S, Ma N, Johnston LJ, Wu C, Ma X. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: a therapeutic target to control intestinal inflammation. Med Res Rev. 2021;41:1061\u201388. https:\/\/doi.org\/10.1002\/med.21752.","journal-title":"Med Res Rev"},{"key":"2164_CR82","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379\u2013401. https:\/\/doi.org\/10.1038\/s41573-019-0016-5.","journal-title":"Nat Rev Drug Discov"},{"key":"2164_CR83","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12967-023-04109-3","volume":"21","author":"FL Zhang","year":"2023","unstructured":"Zhang FL, Chen XW, Wang YF, Hu Z, Zhang WJ, Zhou BW, et al. Microbiota-derived tryptophan metabolites indole-3-lactic acid is associated with intestinal ischemia\/reperfusion injury via positive regulation of YAP and Nrf2. J Transl Med. 2023;21:264. https:\/\/doi.org\/10.1186\/s12967-023-04109-3.","journal-title":"J Transl Med"},{"key":"2164_CR84","doi-asserted-by":"publisher","unstructured":"Cervenka I, Agudelo LZ, Ruas JL. Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health. Science. 2017;357. https:\/\/doi.org\/10.1126\/science.aaf9794.","DOI":"10.1126\/science.aaf9794"},{"key":"2164_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2019.00498","volume":"6","author":"R Pilla","year":"2019","unstructured":"Pilla R, Suchodolski JS. The role of the canine gut microbiome and metabolome in health and gastrointestinal disease. Front Vet Sci. 2019;6: 498. https:\/\/doi.org\/10.3389\/fvets.2019.00498.","journal-title":"Front Vet Sci"},{"key":"2164_CR86","doi-asserted-by":"publisher","first-page":"10678","DOI":"10.1021\/acs.jafc.0c03735","volume":"68","author":"X Zhang","year":"2020","unstructured":"Zhang X, Gan M, Li J, Li H, Su M, Tan D, et al. Endogenous indole pyruvate pathway for tryptophan metabolism mediated by IL4I1. J Agric Food Chem. 2020;68:10678\u201384. https:\/\/doi.org\/10.1021\/acs.jafc.0c03735.","journal-title":"J Agric Food Chem"},{"key":"2164_CR87","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24043163","volume":"24","author":"JM Luo","year":"2023","unstructured":"Luo JM, Zhang TT, He YY, Luo HN, Hong YQ, Yang ZM. Human chorionic gonadotropin-stimulated Interleukin-4-Induced-1 (IL4I1) promotes human decidualization via Aryl Hydrocarbon Receptor. Int J Mol Sci. 2023;24:24. https:\/\/doi.org\/10.3390\/ijms24043163.","journal-title":"Int J Mol Sci."},{"key":"2164_CR88","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.immuni.2018.09.015","volume":"49","author":"S Li","year":"2018","unstructured":"Li S, Bostick JW, Ye J, Qiu J, Zhang B, Urban JF Jr., et al. Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function. Immunity. 2018;49:915\u201328. https:\/\/doi.org\/10.1016\/j.immuni.2018.09.015. .e5.","journal-title":"Immunity"},{"key":"2164_CR89","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551:648\u201352. https:\/\/doi.org\/10.1038\/nature24661.","journal-title":"Nature"},{"key":"2164_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1015386","volume":"12","author":"ZB Huang","year":"2022","unstructured":"Huang ZB, Hu Z, Lu CX, Luo SD, Chen Y, Zhou ZP, et al. Gut microbiota-derived indole 3-propionic acid partially activates aryl hydrocarbon receptor to promote macrophage phagocytosis and attenuate septic injury. Front Cell Infect Microbiol. 2022;12: 1015386. https:\/\/doi.org\/10.3389\/fcimb.2022.1015386.","journal-title":"Front Cell Infect Microbiol"},{"key":"2164_CR91","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2044723","volume":"14","author":"Z Fang","year":"2022","unstructured":"Fang Z, Pan T, Li L, Wang H, Zhu J, Zhang H, et al. Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. Gut Microbes. 2022;14: 2044723. https:\/\/doi.org\/10.1080\/19490976.2022.2044723.","journal-title":"Gut Microbes"},{"key":"2164_CR92","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong CC, Yu J. Gut microbiota in colorectal cancer development and therapy. Nat Rev Clin Oncol. 2023;20:429\u201352. https:\/\/doi.org\/10.1038\/s41571-023-00766-x.","journal-title":"Nat Rev Clin Oncol"},{"key":"2164_CR93","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G. Targeting the gut microbiota for cancer therapy. Nat Rev Cancer. 2022;22:703\u201322. https:\/\/doi.org\/10.1038\/s41568-022-00513-x.","journal-title":"Nat Rev Cancer"},{"key":"2164_CR94","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70:761\u201374. https:\/\/doi.org\/10.1136\/gutjnl-2019-319664.","journal-title":"Gut"},{"key":"2164_CR95","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","volume":"187","author":"D Jia","year":"2024","unstructured":"Jia D, Wang Q, Qi Y, Jiang Y, He J, Lin Y, et al. Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer. Cell. 2024;187:1651\u2013e6521. https:\/\/doi.org\/10.1016\/j.cell.2024.02.022.","journal-title":"Cell"},{"key":"2164_CR96","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2409209","volume":"16","author":"D Jia","year":"2024","unstructured":"Jia D, Kuang Z, Wang L. The role of microbial indole metabolites in tumor. Gut Microbes. 2024;16:2409209. https:\/\/doi.org\/10.1080\/19490976.2024.2409209.","journal-title":"Gut Microbes"},{"key":"2164_CR97","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor. Nat Immunol. 2021;22:358\u201369. https:\/\/doi.org\/10.1038\/s41590-020-00850-9.","journal-title":"Nat Immunol"},{"key":"2164_CR98","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liang X, Dong W, Fang Y, Lv J, Zhang T, et al. Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation. Cancer Cell. 2018;33:480\u201394. https:\/\/doi.org\/10.1016\/j.ccell.2018.02.005.","journal-title":"Cancer Cell"},{"key":"2164_CR99","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mrrev.2018.03.001","volume":"776","author":"FA Boros","year":"2018","unstructured":"Boros FA, Boh\u00e1r Z, V\u00e9csei L. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases. Mutat Res Rev Mutat Res. 2018;776:32\u201345. https:\/\/doi.org\/10.1016\/j.mrrev.2018.03.001.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"2164_CR100","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3945\/ajcn.113.064998","volume":"98","author":"A Ulvik","year":"2013","unstructured":"Ulvik A, Theofylaktopoulou D, Midttun \u00d8, Nyg\u00e5rd O, Eussen SJ, Ueland PM. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. Am J Clin Nutr. 2013;98:934\u201340. https:\/\/doi.org\/10.3945\/ajcn.113.064998.","journal-title":"Am J Clin Nutr"},{"key":"2164_CR101","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.612773","volume":"7","author":"CM Calabrese","year":"2020","unstructured":"Calabrese CM, Valentini A, Calabrese G. Gut microbiota and type 1 diabetes mellitus: the effect of Mediterranean diet. Front Nutr. 2020;7: 612773. https:\/\/doi.org\/10.3389\/fnut.2020.612773.","journal-title":"Front Nutr"},{"key":"2164_CR102","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1016\/0006-2952(74)90178-6","volume":"23","author":"SM el-Sewedy","year":"1974","unstructured":"el-Sewedy SM, Abdel-Tawab GA, el-Zoghby SM, Zeitoun R, Mostafa MH, Shalaby SM. Studies with tryptophan metabolites in vitro. Effect of zinc, manganese, copper and cobalt ions on kynurenine hydrolase and kynurenine aminotransferase in normal mouse liver. Biochem Pharmacol. 1974;23:2557\u201365. https:\/\/doi.org\/10.1016\/0006-2952(74)90178-6.","journal-title":"Biochem Pharmacol"},{"key":"2164_CR103","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","volume":"112","author":"H Fujigaki","year":"2017","unstructured":"Fujigaki H, Yamamoto Y, Saito K. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences. Neuropharmacology. 2017;112:264\u201374. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.01.011.","journal-title":"Neuropharmacology"},{"key":"2164_CR104","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/febs.14026","volume":"284","author":"Y Li","year":"2017","unstructured":"Li Y, Hu N, Yang D, Oxenkrug G, Yang Q. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. Febs j. 2017;284:948\u201366. https:\/\/doi.org\/10.1111\/febs.14026.","journal-title":"Febs j"},{"key":"2164_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/s1462399406000068","volume":"8","author":"JP Ruddick","year":"2006","unstructured":"Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 2006;8:1\u201327. https:\/\/doi.org\/10.1017\/s1462399406000068.","journal-title":"Expert Rev Mol Med"},{"key":"2164_CR106","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.3390\/ijms22094490","volume":"22","author":"KK Wu","year":"2021","unstructured":"Wu KK. Cytoguardin: a tryptophan metabolite against cancer growth and metastasis. Int J Mol Sci. 2021;22:4490. https:\/\/doi.org\/10.3390\/ijms22094490.","journal-title":"Int J Mol Sci"},{"key":"2164_CR107","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.1078197","volume":"299","author":"DJ Walther","year":"2003","unstructured":"Walther DJ, Peter JU, Bashammakh S, H\u00f6rtnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76. https:\/\/doi.org\/10.1126\/science.1078197.","journal-title":"Science"},{"key":"2164_CR108","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/sj.mp.4001716","volume":"10","author":"SM Brown","year":"2005","unstructured":"Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry. 2005;10:884\u20138. https:\/\/doi.org\/10.1038\/sj.mp.4001716.","journal-title":"Mol Psychiatry"},{"key":"2164_CR109","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bcp.2013.02.018","volume":"85","author":"GL Chen","year":"2013","unstructured":"Chen GL, Miller GM. Tryptophan hydroxylase-2: an emerging therapeutic target for stress disorders. Biochem Pharmacol. 2013;85:1227\u201333. https:\/\/doi.org\/10.1016\/j.bcp.2013.02.018.","journal-title":"Biochem Pharmacol"},{"key":"2164_CR110","doi-asserted-by":"publisher","first-page":"1777625","DOI":"10.1080\/2162402x.2020.1777625","volume":"9","author":"J Le Naour","year":"2020","unstructured":"Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2020;9:1777625. https:\/\/doi.org\/10.1080\/2162402x.2020.1777625.","journal-title":"Oncoimmunology"},{"key":"2164_CR111","doi-asserted-by":"publisher","first-page":"1244622","DOI":"10.3389\/fimmu.2023.1244622","volume":"14","author":"S Sultana","year":"2023","unstructured":"Sultana S, Elengickal A, Bensreti H, Belin de Chantem\u00e8le E, McGee-Lawrence ME, Hamrick MW. The kynurenine pathway in HIV, frailty and inflammaging. Front Immunol. 2023;14:1244622. https:\/\/doi.org\/10.3389\/fimmu.2023.1244622.","journal-title":"Front Immunol"},{"key":"2164_CR112","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","volume":"67","author":"Y Suzuki","year":"2010","unstructured":"Suzuki Y, Suda T, Furuhashi K, Suzuki M, Fujie M, Hahimoto D, et al. Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer. Lung Cancer. 2010;67:361\u20135. https:\/\/doi.org\/10.1016\/j.lungcan.2009.05.001.","journal-title":"Lung Cancer"},{"key":"2164_CR113","doi-asserted-by":"publisher","unstructured":"Ghiboub M, Verburgt CM, Sovran B, Benninga MA, de Jonge WJ, Van Limbergen JE. Nutritional therapy to modulate tryptophan metabolism and aryl hydrocarbon-receptor signaling activation in human diseases. Nutrients. 2020;12. https:\/\/doi.org\/10.3390\/nu12092846.","DOI":"10.3390\/nu12092846"},{"key":"2164_CR114","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","volume":"9","author":"HM Roager","year":"2018","unstructured":"Roager HM, Licht TR. Microbial tryptophan catabolites in health and disease. Nat Commun. 2018;9:3294. https:\/\/doi.org\/10.1038\/s41467-018-05470-4.","journal-title":"Nat Commun"},{"key":"2164_CR115","doi-asserted-by":"publisher","first-page":"e2203894119","DOI":"10.1073\/pnas.2203894119","volume":"119","author":"W Chen","year":"2022","unstructured":"Chen W, Wen L, Bao Y, Tang Z, Zhao J, Zhang X, et al. Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and up-regulating SREBP2. Proc Natl Acad Sci U S A. 2022;119:e2203894119. https:\/\/doi.org\/10.1073\/pnas.2203894119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2164_CR116","doi-asserted-by":"publisher","first-page":"e2204006","DOI":"10.1002\/advs.202204006","volume":"10","author":"D Liu","year":"2023","unstructured":"Liu D, Liang CH, Huang B, Zhuang X, Cui W, Yang L, et al. Tryptophan Metabolism Acts as a New Anti-Ferroptotic Pathway to Mediate Tumor Growth. Adv Sci (Weinh). 2023;10:e2204006. https:\/\/doi.org\/10.1002\/advs.202204006.","journal-title":"Adv Sci (Weinh)"},{"key":"2164_CR117","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.Can-12-0549","volume":"72","author":"S Adams","year":"2012","unstructured":"Adams S, Braidy N, Bessede A, Brew BJ, Grant R, Teo C, et al. The kynurenine pathway in brain tumor pathogenesis. Cancer Res. 2012;72:5649\u201357. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0549.","journal-title":"Cancer Res"},{"key":"2164_CR118","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25:131\u201347. https:\/\/doi.org\/10.1038\/s41380-019-0414-4.","journal-title":"Mol Psychiatry"},{"key":"2164_CR119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","volume":"39","author":"JE Cheong","year":"2018","unstructured":"Cheong JE, Sun L. Targeting the IDO1\/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities. Trends Pharmacol Sci. 2018;39:307\u201325. https:\/\/doi.org\/10.1016\/j.tips.2017.11.007.","journal-title":"Trends Pharmacol Sci"},{"key":"2164_CR120","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41398-023-02687-w","volume":"13","author":"JM Launay","year":"2023","unstructured":"Launay JM, Delorme R, Pagan C, Callebert J, Leboyer M, Vodovar N. Impact of IDO activation and alterations in the kynurenine pathway on hyperserotonemia, NAD(+) production, and AhR activation in autism spectrum disorder. Transl Psychiatry. 2023;13:380. https:\/\/doi.org\/10.1038\/s41398-023-02687-w.","journal-title":"Transl Psychiatry"},{"key":"2164_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.997240","volume":"13","author":"M Fathi","year":"2022","unstructured":"Fathi M, Vakili K, Yaghoobpoor S, Tavasol A, Jazi K, Hajibeygi R, et al. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer\u2019s disease, Parkinson\u2019s disease, and Huntington\u2019s disease: A systematic Review and meta-analysis. Front Immunol. 2022;13:997240. https:\/\/doi.org\/10.3389\/fimmu.2022.997240.","journal-title":"Front Immunol"},{"key":"2164_CR122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/cells9061564","volume":"9","author":"T Biernacki","year":"2020","unstructured":"Biernacki T, Sandi D, Bencsik K, V\u00e9csei L. Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives. Cells. 2020;9. doi: 10.3390\/cells9061564.","journal-title":"Cells"},{"key":"2164_CR123","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpsychires.2021.05.004","volume":"139","author":"P Zhang","year":"2021","unstructured":"Zhang P, Huang J, Gou M, Zhou Y, Tong J, Fan F, et al. Kynurenine metabolism and metabolic syndrome in patients with schizophrenia. J Psychiatr Res. 2021;139:54\u201361. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.05.004.","journal-title":"J Psychiatr Res"},{"key":"2164_CR124","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-018-0255-3","volume":"20","author":"PS Minhas","year":"2019","unstructured":"Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, et al. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nat Immunol. 2019;20:50\u201363. https:\/\/doi.org\/10.1038\/s41590-018-0255-3.","journal-title":"Nat Immunol"},{"key":"2164_CR125","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204697","volume":"9","author":"B Xu","year":"2022","unstructured":"Xu B, Zhang P, Tang X, Wang S, Shen J, Zheng Y, et al. Metabolic Rewiring of Kynurenine Pathway during Hepatic Ischemia-Reperfusion Injury Exacerbates Liver Damage by Impairing NAD Homeostasis. Adv Sci (Weinh). 2022;9:e2204697. https:\/\/doi.org\/10.1002\/advs.202204697.","journal-title":"Adv Sci (Weinh)"},{"key":"2164_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113518","volume":"42","author":"J Wan","year":"2023","unstructured":"Wan J, Cheng C, Hu J, Huang H, Han Q, Jie Z, et al. De novo NAD(+) synthesis contributes to CD8(+) T cell metabolic fitness and antitumor function. Cell Rep. 2023;42:113518. https:\/\/doi.org\/10.1016\/j.celrep.2023.113518.","journal-title":"Cell Rep"},{"key":"2164_CR127","doi-asserted-by":"publisher","first-page":"698","DOI":"10.14336\/ad.2021.0824","volume":"13","author":"M Dehhaghi","year":"2022","unstructured":"Dehhaghi M, Panahi HKS, Kavyani B, Heng B, Tan V, Braidy N, et al. The Role of Kynurenine Pathway and NAD(+) Metabolism in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Aging Dis. 2022;13:698\u2013711. https:\/\/doi.org\/10.14336\/ad.2021.0824.","journal-title":"Aging Dis"},{"key":"2164_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115395","volume":"166","author":"J Gao","year":"2023","unstructured":"Gao J, Yang T, Song B, Ma X, Ma Y, Lin X, et al. Abnormal tryptophan catabolism in diabetes mellitus and its complications: Opportunities and challenges. Biomed Pharmacother. 2023;166:115395. https:\/\/doi.org\/10.1016\/j.biopha.2023.115395.","journal-title":"Biomed Pharmacother"},{"key":"2164_CR129","doi-asserted-by":"publisher","first-page":"12675","DOI":"10.1038\/s41598-020-69559-x","volume":"10","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Li Y, Benkowitz P, Lamina C, K\u00f6ttgen A, Sekula P. The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis. Sci Rep. 2020;10:12675. https:\/\/doi.org\/10.1038\/s41598-020-69559-x.","journal-title":"Sci Rep"},{"key":"2164_CR130","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10194-023-01708-9","volume":"25","author":"J Liu","year":"2024","unstructured":"Liu J, Xi K, Zhang L, Han M, Wang Q, Liu X. Tryptophan metabolites and gut microbiota play an important role in pediatric migraine diagnosis. J Headache Pain. 2024;25:2. https:\/\/doi.org\/10.1186\/s10194-023-01708-9.","journal-title":"J Headache Pain"},{"key":"2164_CR131","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1373\/clinchem.2018.288720","volume":"64","author":"E Yu","year":"2018","unstructured":"Yu E, Papandreou C, Ruiz-Canela M, Guasch-Ferre M, Clish CB, Dennis C, et al. Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study. Clin Chem. 2018;64:1211\u201320. https:\/\/doi.org\/10.1373\/clinchem.2018.288720.","journal-title":"Clin Chem"},{"key":"2164_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768560","volume":"12","author":"R G\u00e1sp\u00e1r","year":"2021","unstructured":"G\u00e1sp\u00e1r R, Halmi D, Demj\u00e1n V, Berkecz R, Pipicz M, Csont T. Kynurenine Pathway Metabolites as Potential Clinical Biomarkers in Coronary Artery Disease. Front Immunol. 2021;12:768560. https:\/\/doi.org\/10.3389\/fimmu.2021.768560.","journal-title":"Front Immunol"},{"key":"2164_CR133","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1021\/acs.jpcb.2c05848","volume":"126","author":"T Haldar","year":"2022","unstructured":"Haldar T, Chatterjee S, Alam MN, Maity P, Bagchi S. Blue Fluorescence of Cyano-tryptophan Predicts Local Electrostatics and Hydrogen Bonding in Biomolecules. J Phys Chem B. 2022;126:10732\u201340. https:\/\/doi.org\/10.1021\/acs.jpcb.2c05848.","journal-title":"J Phys Chem B"},{"key":"2164_CR134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/molecules25173819","volume":"25","author":"MB Vaughn","year":"2020","unstructured":"Vaughn MB, Biren C, Li Q, Ragupathi A, Dyer RB. Site-Specific Tryptophan Labels Reveal Local Microsecond-Millisecond Motions of Dihydrofolate Reductase. Molecules. 2020;25. doi: 10.3390\/molecules25173819.","journal-title":"Molecules."},{"key":"2164_CR135","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1021\/acs.jpcb.1c08600","volume":"126","author":"S Pal","year":"2022","unstructured":"Pal S, Bose D, Chakrabarti A, Chattopadhyay A. Comparative Analysis of Tryptophan Dynamics in Spectrin and Its Constituent Domains: Insights from Fluorescence. J Phys Chem B. 2022;126:1045\u201353. https:\/\/doi.org\/10.1021\/acs.jpcb.1c08600.","journal-title":"J Phys Chem B"},{"key":"2164_CR136","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1021\/acs.nanolett.2c03797","volume":"23","author":"P Roy","year":"2023","unstructured":"Roy P, Claude JB, Tiwari S, Barulin A, Wenger J. Ultraviolet Nanophotonics Enables Autofluorescence Correlation Spectroscopy on Label-Free Proteins with a Single Tryptophan. Nano Lett. 2023;23:497\u2013504. https:\/\/doi.org\/10.1021\/acs.nanolett.2c03797.","journal-title":"Nano Lett"},{"key":"2164_CR137","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1515\/cclm-2022-0790","volume":"61","author":"SKM van Zundert","year":"2023","unstructured":"van Zundert SKM, Griffioen PH, van Rossem L, Willemsen SP, de Rijke YB, van Schaik RHN, et al. Simultaneous quantification of tryptophan metabolites by liquid chromatography tandem mass spectrometry during early human pregnancy. Clin Chem Lab Med. 2023;61:442\u201351. https:\/\/doi.org\/10.1515\/cclm-2022-0790.","journal-title":"Clin Chem Lab Med"},{"key":"2164_CR138","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jchromb.2019.02.021","volume":"1112","author":"LS Wang","year":"2019","unstructured":"Wang LS, Zhang MD, Tao X, Zhou YF, Liu XM, Pan RL, et al. LC-MS\/MS-based quantification of tryptophan metabolites and neurotransmitters in the serum and brain of mice. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1112:24\u201332. https:\/\/doi.org\/10.1016\/j.jchromb.2019.02.021.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2164_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114979","volume":"219","author":"M Dai","year":"2022","unstructured":"Dai M, Wang Q, Kou S, Li X, Jiang Z, Sun L, et al. A sensitive UPLC-MS\/MS method for the simultaneous determination of the metabolites in the tryptophan pathway in rat plasma. J Pharm Biomed Anal. 2022;219: 114979. https:\/\/doi.org\/10.1016\/j.jpba.2022.114979.","journal-title":"J Pharm Biomed Anal"},{"key":"2164_CR140","doi-asserted-by":"publisher","first-page":"12554","DOI":"10.1038\/s41598-023-39774-3","volume":"13","author":"B Pedraz-Petrozzi","year":"2023","unstructured":"Pedraz-Petrozzi B, Marszalek-Grabska M, Kozub A, Szalaj K, Trzpil A, Stachniuk A, et al. LC-MS\/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples. Sci Rep. 2023;13:12554. https:\/\/doi.org\/10.1038\/s41598-023-39774-3.","journal-title":"Sci Rep"},{"key":"2164_CR141","doi-asserted-by":"publisher","first-page":"9851","DOI":"10.3168\/jds.2020-18260","volume":"103","author":"M Su","year":"2020","unstructured":"Su M, Cheng Y, Zhang C, Zhu D, Jia M, Zhang Q, et al. Determination of the levels of tryptophan and 12 metabolites in milk by liquid chromatography-tandem mass spectrometry with the QuEChERS method. J Dairy Sci. 2020;103:9851\u20139. https:\/\/doi.org\/10.3168\/jds.2020-18260.","journal-title":"J Dairy Sci"},{"key":"2164_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1140054","volume":"10","author":"D Hu","year":"2023","unstructured":"Hu D, Liu J, Yu W, Li C, Huang L, Mao W, et al. Tryptophan intake, not always the more the better. Front Nutr. 2023;10: 1140054. https:\/\/doi.org\/10.3389\/fnut.2023.1140054.","journal-title":"Front Nutr"},{"key":"2164_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185985","volume":"14","author":"X Liang","year":"2023","unstructured":"Liang X, Gao H, Xiao J, Han S, He J, Yuan R, et al. Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma. Front Immunol. 2023;14: 1185985. https:\/\/doi.org\/10.3389\/fimmu.2023.1185985.","journal-title":"Front Immunol"},{"key":"2164_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154852","volume":"116","author":"T Wang","year":"2023","unstructured":"Wang T, Song Y, Ai Z, Liu Y, Li H, Xu W, et al. Pulsatilla chinensis saponins ameliorated murine depression by inhibiting intestinal inflammation mediated IDO1 overexpression and rebalancing tryptophan metabolism. Phytomedicine. 2023;116: 154852. https:\/\/doi.org\/10.1016\/j.phymed.2023.154852.","journal-title":"Phytomedicine"},{"key":"2164_CR145","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1002\/acn3.51383","volume":"8","author":"Y Luo","year":"2021","unstructured":"Luo Y, M\u00f6hn N, Skripuletz T, Senel M, Tumani H, Pe\u00dfler F, et al. Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway. Ann Clin Transl Neurol. 2021;8:2228\u201334. https:\/\/doi.org\/10.1002\/acn3.51383.","journal-title":"Ann Clin Transl Neurol"},{"key":"2164_CR146","doi-asserted-by":"publisher","first-page":"12139","DOI":"10.1002\/cam4.5903","volume":"12","author":"D Guo","year":"2023","unstructured":"Guo D, Wang Y, Wu X, Gao Y, Wang A, Zhang Z, et al. Expression of tryptophan metabolism enzymes in patients with diffuse large B-cell lymphoma and NK\/T-cell lymphoma. Cancer Med. 2023;12:12139\u201348. https:\/\/doi.org\/10.1002\/cam4.5903.","journal-title":"Cancer Med"},{"key":"2164_CR147","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.nucmedbio.2012.01.010","volume":"39","author":"C Juh\u00e1sz","year":"2012","unstructured":"Juh\u00e1sz C, Nahleh Z, Zitron I, Chugani DC, Janabi MZ, Bandyopadhyay S, et al. Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol. 2012;39:926\u201332. https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.01.010.","journal-title":"Nucl Med Biol"},{"key":"2164_CR148","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/tp.0000000000000603","volume":"99","author":"D Vavrincova-Yaghi","year":"2015","unstructured":"Vavrincova-Yaghi D, Seelen MA, Kema IP, Deelman LE, van der Heuvel MC, Breukelman H, et al. Early posttransplant tryptophan metabolism predicts long-term outcome of human kidney transplantation. Transplantation. 2015;99:e97\u2013104. https:\/\/doi.org\/10.1097\/tp.0000000000000603.","journal-title":"Transplantation"},{"key":"2164_CR149","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1021\/acs.analchem.9b04210","volume":"92","author":"VY Rubio","year":"2020","unstructured":"Rubio VY, Cagmat JG, Wang GP, Yost RA, Garrett TJ. Analysis of tryptophan metabolites in serum using wide-isolation strategies for UHPLC-HRMS\/MS. Anal Chem. 2020;92:2550\u20137. https:\/\/doi.org\/10.1021\/acs.analchem.9b04210.","journal-title":"Anal Chem"},{"key":"2164_CR150","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.talanta.2018.11.094","volume":"195","author":"A Lef\u00e8vre","year":"2019","unstructured":"Lef\u00e8vre A, Mavel S, Nadal-Desbarats L, Galineau L, Attucci S, Dufour D, et al. Validation of a global quantitative analysis methodology of tryptophan metabolites in mice using LC-MS. Talanta. 2019;195:593\u20138. https:\/\/doi.org\/10.1016\/j.talanta.2018.11.094.","journal-title":"Talanta"},{"key":"2164_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2021.462294","volume":"1651","author":"A Chawdhury","year":"2021","unstructured":"Chawdhury A, Shamsi SA, Miller A, Liu A. Capillary electrochromatography-mass spectrometry of kynurenine pathway metabolites. J Chromatogr A. 2021;1651: 462294. https:\/\/doi.org\/10.1016\/j.chroma.2021.462294.","journal-title":"J Chromatogr A"},{"key":"2164_CR152","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/elps.202200251","volume":"44","author":"VD Patel","year":"2023","unstructured":"Patel VD, Shamsi SA, Miller A, Liu A. Quantitation of tryptophan and kynurenine in human plasma using 4-vinylphenylboronic acid column by capillary electrochromatography coupled with mass spectrometry. Electrophoresis. 2023;44:529\u201339. https:\/\/doi.org\/10.1002\/elps.202200251.","journal-title":"Electrophoresis"},{"key":"2164_CR153","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/molecules25143258","volume":"25","author":"A Pautova","year":"2020","unstructured":"Pautova A, Khesina Z, Getsina M, Sobolev P, Revelsky A, Beloborodova N. Determination of tryptophan metabolites in serum and cerebrospinal fluid samples using microextraction by packed sorbent, Silylation and GC-MS detection. Molecules. 2020;25:25. https:\/\/doi.org\/10.3390\/molecules25143258.","journal-title":"Molecules."},{"key":"2164_CR154","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.chroma.2017.05.008","volume":"1504","author":"H Guo","year":"2017","unstructured":"Guo H, Jiao Y, Wang X, Lu T, Zhang Z, Xu F. Twins labeling-liquid chromatography\/mass spectrometry based metabolomics for absolute quantification of tryptophan and its key metabolites. J Chromatogr A. 2017;1504:83\u201390. https:\/\/doi.org\/10.1016\/j.chroma.2017.05.008.","journal-title":"J Chromatogr A"},{"key":"2164_CR155","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.3390\/molecules23113012","volume":"23","author":"J Flieger","year":"2018","unstructured":"Flieger J, \u015awi\u0119ch-Zubilewicz A, \u015aniegocki T, Dolar-Szczasny J, Pizo\u0144 M. Determination of tryptophan and its major metabolites in fluid from the anterior chamber of the eye in diabetic patients with cataract by liquid chromotography mass spectrometry (LC-MS\/MS). Molecules. 2018;23:3012. https:\/\/doi.org\/10.3390\/molecules23113012.","journal-title":"Molecules"},{"key":"2164_CR156","doi-asserted-by":"publisher","first-page":"461775","DOI":"10.1016\/j.chroma.2020.461775","volume":"1635","author":"Z Galla","year":"2021","unstructured":"Galla Z, Rajda C, R\u00e1cz G, Grecs\u00f3 N, Bar\u00e1th \u00c1, V\u00e9csei L, et al. Simultaneous determination of 30 neurologically and metabolically important molecules: a sensitive and selective way to measure tyrosine and tryptophan pathway metabolites and other biomarkers in human serum and cerebrospinal fluid. J Chromatogr A. 2021;1635:461775. https:\/\/doi.org\/10.1016\/j.chroma.2020.461775.","journal-title":"J Chromatogr A"},{"key":"2164_CR157","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1007\/s00216-017-0486-4","volume":"409","author":"JS Oh","year":"2017","unstructured":"Oh JS, Seo HS, Kim KH, Pyo H, Chung BC, Lee J. Urinary profiling of tryptophan and its related metabolites in patients with metabolic syndrome by liquid chromatography-electrospray ionization\/mass spectrometry. Anal Bioanal Chem. 2017;409:5501\u201312. https:\/\/doi.org\/10.1007\/s00216-017-0486-4.","journal-title":"Anal Bioanal Chem"},{"key":"2164_CR158","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1021\/jm2006782","volume":"54","author":"E Dolusi\u0107","year":"2011","unstructured":"Dolusi\u0107 E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, et al. Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators. J Med Chem. 2011;54:5320\u201334. https:\/\/doi.org\/10.1021\/jm2006782.","journal-title":"J Med Chem"},{"key":"2164_CR159","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.trecan.2017.11.005","volume":"4","author":"GC Prendergast","year":"2018","unstructured":"Prendergast GC, Mondal A, Dey S, Laury-Kleintop LD, Muller AJ. Inflammatory reprogramming with IDO1 inhibitors: turning immunologically unresponsive \u2018Cold\u2019 Tumors \u2018Hot.\u2019 Trends Cancer. 2018;4:38\u201358. https:\/\/doi.org\/10.1016\/j.trecan.2017.11.005.","journal-title":"Trends Cancer"},{"key":"2164_CR160","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1080\/14756366.2021.1882451","volume":"36","author":"I Sadok","year":"2021","unstructured":"Sadok I, Rachwa\u0142 K, Jonik I, Staniszewska M. Reliable chromatographic assay for measuring of indoleamine 2,3-dioxygenase 1 (IDO1) activity in human cancer cells. J Enzyme Inhib Med Chem. 2021;36:581\u201392. https:\/\/doi.org\/10.1080\/14756366.2021.1882451.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2164_CR161","doi-asserted-by":"publisher","first-page":"122928","DOI":"10.1016\/j.saa.2023.122928","volume":"301","author":"KM Abou El-Nour","year":"2023","unstructured":"Abou El-Nour KM, El-Sherbiny IM, Khairy GM, Abbas AM, Salem EH. Investigation of thymine as a potential cancer biomarker employing tryptophan with nanomaterials as a biosensor. Spectrochim Acta Mol Biomol Spectrosc. 2023;301:122928. https:\/\/doi.org\/10.1016\/j.saa.2023.122928.","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"2164_CR162","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41598-020-79903-w","volume":"11","author":"S Jankovskaja","year":"2021","unstructured":"Jankovskaja S, Engblom J, Rezeli M, Marko-Varga G, Ruzgas T, Bj\u00f6rklund S. Non-invasive skin sampling of tryptophan\/kynurenine ratio in vitro towards a skin cancer biomarker. Sci Rep. 2021;11:678. https:\/\/doi.org\/10.1038\/s41598-020-79903-w.","journal-title":"Sci Rep"},{"key":"2164_CR163","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.Cir-19-0041","volume":"8","author":"F Schramme","year":"2020","unstructured":"Schramme F, Crosignani S, Frederix K, Hoffmann D, Pilotte L, Stroobant V, et al. Inhibition of tryptophan-dioxygenase activity increases the antitumor efficacy of immune checkpoint inhibitors. Cancer Immunol Res. 2020;8:32\u201345. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0041.","journal-title":"Cancer Immunol Res"},{"key":"2164_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114625","volume":"241","author":"C Huo","year":"2022","unstructured":"Huo C, Luo Z, Ning X, Kang X, Yan Q, Guo Y, et al. 4,6-disubstituted-1H-Indazole-4-Amine derivatives with immune-chemotherapy effect and in vivo antitumor activity. Eur J Med Chem. 2022;241: 114625. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114625.","journal-title":"Eur J Med Chem"},{"key":"2164_CR165","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejmech.2018.10.017","volume":"160","author":"S Zhang","year":"2018","unstructured":"Zhang S, Qi F, Fang X, Yang D, Hu H, Huang Q, et al. Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives. Eur J Med Chem. 2018;160:133\u201345. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.017.","journal-title":"Eur J Med Chem"},{"key":"2164_CR166","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1158\/2326-6066.Cir-19-0040","volume":"8","author":"D Hoffmann","year":"2020","unstructured":"Hoffmann D, Dvorakova T, Stroobant V, Bouzin C, Daumerie A, Solvay M, et al. Tryptophan 2,3-dioxygenase expression identified in human hepatocellular carcinoma cells and in intratumoral pericytes of most cancers. Cancer Immunol Res. 2020;8:19\u201331. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-0040.","journal-title":"Cancer Immunol Res"},{"key":"2164_CR167","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1158\/1078-0432.Ccr-21-1392","volume":"27","author":"L Zhai","year":"2021","unstructured":"Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Nguyen B, et al. Tumor Cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma. Clin Cancer Res. 2021;27:6514\u201328. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-1392.","journal-title":"Clin Cancer Res"},{"key":"2164_CR168","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12885-022-09569-2","volume":"22","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo Z, Xie Q, Zhong C, Gao X, Yang Q. Tryptophan hydroxylase 1 drives glioma progression by modulating the serotonin\/L1CAM\/NF-\u03baB signaling pathway. BMC Cancer. 2022;22:457. https:\/\/doi.org\/10.1186\/s12885-022-09569-2.","journal-title":"BMC Cancer"},{"key":"2164_CR169","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.1158\/1078-0432.Ccr-12-2130","volume":"18","author":"DA Wainwright","year":"2012","unstructured":"Wainwright DA, Balyasnikova IV, Chang AL, Ahmed AU, Moon KS, Auffinger B, et al. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival. Clin Cancer Res. 2012;18:6110\u201321. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2130.","journal-title":"Clin Cancer Res"},{"key":"2164_CR170","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1227\/NEU.0b013e31828cf945","volume":"72","author":"K Mitsuka","year":"2013","unstructured":"Mitsuka K, Kawataki T, Satoh E, Asahara T, Horikoshi T, Kinouchi H. Expression of indoleamine 2,3-dioxygenase and correlation with pathological malignancy in gliomas. Neurosurgery. 2013;72:1031\u20138. https:\/\/doi.org\/10.1227\/NEU.0b013e31828cf945. discussion 8\u20139.","journal-title":"Neurosurgery"},{"key":"2164_CR171","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-019-0103-4","volume":"5","author":"L Du","year":"2020","unstructured":"Du L, Xing Z, Tao B, Li T, Yang D, Li W, et al. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway. Signal Transduct Target Ther. 2020;5:10. https:\/\/doi.org\/10.1038\/s41392-019-0103-4.","journal-title":"Signal Transduct Target Ther"},{"key":"2164_CR172","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/neuonc\/nov098","volume":"17","author":"E Bosny\u00e1k","year":"2015","unstructured":"Bosny\u00e1k E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ, et al. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro Oncol. 2015;17:1284\u201392. https:\/\/doi.org\/10.1093\/neuonc\/nov098.","journal-title":"Neuro Oncol"},{"key":"2164_CR173","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1111\/febs.17109","volume":"291","author":"IL Dos Santos","year":"2024","unstructured":"Dos Santos IL, Mitchell M, Nogueira PAS, Lafita-Navarro MC, Perez-Castro L, Eriom J, et al. Targeting of neuroblastoma cells through Kynurenine-AHR pathway inhibition. Febs J. 2024;291:2172\u201390. https:\/\/doi.org\/10.1111\/febs.17109.","journal-title":"Febs J"},{"key":"2164_CR174","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1101\/gad.327056.119","volume":"33","author":"N Venkateswaran","year":"2019","unstructured":"Venkateswaran N, Lafita-Navarro MC, Hao YH, Kilgore JA, Perez-Castro L, Braverman J, et al. MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer. Genes Dev. 2019;33:1236\u201351. https:\/\/doi.org\/10.1101\/gad.327056.119.","journal-title":"Genes Dev"},{"key":"2164_CR175","first-page":"6006","volume":"7","author":"F Huang","year":"2014","unstructured":"Huang F, Zhao Y, Zhao J, Wu S, Jiang Y, Ma H, et al. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer. Int J Clin Exp Pathol. 2014;7:6006\u201314.","journal-title":"Int J Clin Exp Pathol"},{"key":"2164_CR176","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms18081632","volume":"18","author":"K Toda","year":"2017","unstructured":"Toda K, Nishikawa G, Iwamoto M, Itatani Y, Takahashi R, Sakai Y, et al. Clinical role of ASCT2 (SLC1A5) in KRAS-Mutated colorectal cancer. Int J Mol Sci. 2017;18:18. https:\/\/doi.org\/10.3390\/ijms18081632.","journal-title":"Int J Mol Sci."},{"key":"2164_CR177","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1186\/s12885-022-10357-1","volume":"22","author":"C Takasu","year":"2022","unstructured":"Takasu C, Nishi M, Yoshikawa K, Tokunaga T, Nakao T, Kashihara H, et al. Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. BMC Cancer. 2022;22:1263. https:\/\/doi.org\/10.1186\/s12885-022-10357-1.","journal-title":"BMC Cancer"},{"key":"2164_CR178","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1016\/j.molcel.2021.03.019","volume":"81","author":"AC Newman","year":"2021","unstructured":"Newman AC, Falcone M, Huerta Uribe A, Zhang T, Athineos D, Pietzke M, et al. Immune-regulated IDO1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells. Mol Cell. 2021;81:2290\u2013302. https:\/\/doi.org\/10.1016\/j.molcel.2021.03.019.","journal-title":"Mol Cell"},{"key":"2164_CR179","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.canlet.2021.09.012","volume":"522","author":"H Liang","year":"2021","unstructured":"Liang H, Li T, Fang X, Xing Z, Zhang S, Shi L, et al. IDO1\/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer. Cancer Lett. 2021;522:32\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.012.","journal-title":"Cancer Lett"},{"key":"2164_CR180","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41401-022-01035-w","volume":"44","author":"H Buhe","year":"2023","unstructured":"Buhe H, Ma JX, Ye FZ, Song CY, Chen XY, Liu Y, et al. IDO-1 inhibitor INCB24360 elicits distant metastasis of basal extruded cancer cells in pancreatic ductal adenocarcinoma. Acta Pharmacol Sin. 2023;44:1277\u201389. https:\/\/doi.org\/10.1038\/s41401-022-01035-w.","journal-title":"Acta Pharmacol Sin"},{"key":"2164_CR181","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD, et al. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature. 2023;615:168\u201374. https:\/\/doi.org\/10.1038\/s41586-023-05728-y.","journal-title":"Nature"},{"key":"2164_CR182","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12935-021-02228-9","volume":"21","author":"Z Wu","year":"2021","unstructured":"Wu Z, Yan L, Lin J, Ke K, Yang W. Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway. Cancer Cell Int. 2021;21:538. https:\/\/doi.org\/10.1186\/s12935-021-02228-9.","journal-title":"Cancer Cell Int"},{"key":"2164_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.697","volume":"12","author":"Z Shi","year":"2022","unstructured":"Shi Z, Gan G, Gao X, Chen F, Mi J. Kynurenine catabolic enzyme KMO regulates HCC growth. Clin Transl Med. 2022;12: e697. https:\/\/doi.org\/10.1002\/ctm2.697.","journal-title":"Clin Transl Med"},{"key":"2164_CR184","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-023-02629-w","volume":"42","author":"JX Cui","year":"2023","unstructured":"Cui JX, Xu XH, He T, Liu JJ, Xie TY, Tian W, et al. L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis. J Exp Clin Cancer Res. 2023;42:52. https:\/\/doi.org\/10.1186\/s13046-023-02629-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"2164_CR185","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.1002\/cam4.2596","volume":"8","author":"F Li","year":"2019","unstructured":"Li F, Sun Y, Huang J, Xu W, Liu J, Yuan Z. CD4\/CD8\u2009+\u2009T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Cancer Med. 2019;8:7330\u201344. https:\/\/doi.org\/10.1002\/cam4.2596.","journal-title":"Cancer Med"},{"key":"2164_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/srep21319","volume":"6","author":"H Liu","year":"2016","unstructured":"Liu H, Shen Z, Wang Z, Wang X, Zhang H, Qin J, et al. Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma. Sci Rep. 2016;6: 21319. https:\/\/doi.org\/10.1038\/srep21319.","journal-title":"Sci Rep"},{"key":"2164_CR187","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/0008-5472.Can-10-3403","volume":"71","author":"RB S\u00f8rensen","year":"2011","unstructured":"S\u00f8rensen RB, K\u00f8llgaard T, Andersen RS, van den Berg JH, Svane IM, Straten P, et al. Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2. Cancer Res. 2011;71:2038\u201344. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-3403.","journal-title":"Cancer Res"},{"key":"2164_CR188","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2023.2204753","volume":"12","author":"JD Oldan","year":"2023","unstructured":"Oldan JD, Giglio BC, Smith E, Zhao W, Bouchard DM, Ivanovic M, et al. Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III\/IV melanoma. Oncoimmunology. 2023;12: 2204753. https:\/\/doi.org\/10.1080\/2162402x.2023.2204753.","journal-title":"Oncoimmunology"},{"key":"2164_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111196","volume":"125","author":"L Xue","year":"2023","unstructured":"Xue L, Wang C, Qian Y, Zhu W, Liu L, Yang X, et al. Tryptophan metabolism regulates inflammatory macrophage polarization as a predictive factor for breast cancer immunotherapy. Int Immunopharmacol. 2023;125: 111196. https:\/\/doi.org\/10.1016\/j.intimp.2023.111196.","journal-title":"Int Immunopharmacol"},{"key":"2164_CR190","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41379-018-0061-3","volume":"31","author":"EA Dill","year":"2018","unstructured":"Dill EA, Dillon PM, Bullock TN, Mills AM. IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1. Mod Pathol. 2018;31:1513\u201322. https:\/\/doi.org\/10.1038\/s41379-018-0061-3.","journal-title":"Mod Pathol"},{"key":"2164_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090409","volume":"9","author":"D Duarte","year":"2019","unstructured":"Duarte D, Amaro F, Silva I, Silva D, Fresco P, Oliveira JC, et al. Carbidopa Alters tryptophan metabolism in breast cancer and melanoma cells leading to the formation of Indole-3-Acetonitrile, a pro-proliferative metabolite. Biomolecules. 2019;9: 9. https:\/\/doi.org\/10.3390\/biom9090409.","journal-title":"Biomolecules."},{"key":"2164_CR192","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6201764","volume":"2019","author":"YH Chiu","year":"2019","unstructured":"Chiu YH, Lei HJ, Huang KC, Chiang YL, Lin CS. Overexpression of kynurenine 3-monooxygenase correlates with cancer malignancy and predicts poor prognosis in canine mammary gland tumors. J Oncol. 2019;2019: 6201764. https:\/\/doi.org\/10.1155\/2019\/6201764.","journal-title":"J Oncol"},{"key":"2164_CR193","doi-asserted-by":"publisher","first-page":"21996","DOI":"10.1002\/cam4.6778","volume":"12","author":"S Zhang","year":"2023","unstructured":"Zhang S, Gao Y, Wang P, Wang S, Wang Y, Li M, et al. Tryptophan metabolism enzymes are potential targets in ovarian clear cell carcinoma. Cancer Med. 2023;12:21996\u20132005. https:\/\/doi.org\/10.1002\/cam4.6778.","journal-title":"Cancer Med"},{"key":"2164_CR194","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/0008-5472.Can-17-2995","volume":"78","author":"W Wang","year":"2018","unstructured":"Wang W, Huang L, Jin JY, Jolly S, Zang Y, Wu H, et al. IDO immune status after chemoradiation may predict survival in lung cancer patients. Cancer Res. 2018;78:809\u201316. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2995.","journal-title":"Cancer Res"},{"key":"2164_CR195","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12885-022-09877-7","volume":"22","author":"H Feng","year":"2022","unstructured":"Feng H, Cao B, Peng X, Wei Q. Cancer-associated fibroblasts strengthen cell proliferation and EGFR TKIs resistance through aryl hydrocarbon receptor dependent signals in non-small cell lung cancer. BMC Cancer. 2022;22:764. https:\/\/doi.org\/10.1186\/s12885-022-09877-7.","journal-title":"BMC Cancer"},{"key":"2164_CR196","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3171\/2008.10.Jns081141","volume":"111","author":"T Miyazaki","year":"2009","unstructured":"Miyazaki T, Moritake K, Yamada K, Hara N, Osago H, Shibata T, et al. Indoleamine 2,3-dioxygenase as a new target for malignant glioma therapy. Laboratory investigation. J Neurosurg. 2009;111:230\u20137. https:\/\/doi.org\/10.3171\/2008.10.Jns081141.","journal-title":"J Neurosurg"},{"key":"2164_CR197","doi-asserted-by":"publisher","unstructured":"Koch MS, Zdioruk M, Nowicki MO, Griffith AM, Aguilar E, Aguilar LK, et al. Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models. J Immunother Cancer. 2022;10. https:\/\/doi.org\/10.1136\/jitc-2021-003368.","DOI":"10.1136\/jitc-2021-003368"},{"key":"2164_CR198","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/ijc.32325","volume":"145","author":"I Koske","year":"2019","unstructured":"Koske I, R\u00f6ssler A, Pipperger L, Petersson M, Barnstorf I, Kimpel J, et al. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment. Int J Cancer. 2019;145:1958\u201369. https:\/\/doi.org\/10.1002\/ijc.32325.","journal-title":"Int J Cancer"},{"key":"2164_CR199","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14728214.2016.1186643","volume":"21","author":"R Desai","year":"2016","unstructured":"Desai R, Suryadevara CM, Batich KA, Farber SH, Sanchez-Perez L, Sampson JH. Emerging immunotherapies for glioblastoma. Expert Opin Emerg Drugs. 2016;21:133\u201345. https:\/\/doi.org\/10.1080\/14728214.2016.1186643.","journal-title":"Expert Opin Emerg Drugs"},{"key":"2164_CR200","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1022302","volume":"4","author":"J Qiao","year":"2015","unstructured":"Qiao J, Dey M, Chang AL, Kim JW, Miska J, Ling A, et al. Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy. Oncoimmunology. 2015;4:e1022302. https:\/\/doi.org\/10.1080\/2162402x.2015.1022302.","journal-title":"Oncoimmunology"},{"key":"2164_CR201","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.Can-20-2489","volume":"81","author":"T Ma","year":"2021","unstructured":"Ma T, Hu C, Lal B, Zhou W, Ma Y, Ying M, et al. Reprogramming transcription factors Oct4 and Sox2 induce a BRD-dependent immunosuppressive transcriptome in GBM-propagating cells. Cancer Res. 2021;81:2457\u201369. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-2489.","journal-title":"Cancer Res"},{"key":"2164_CR202","doi-asserted-by":"publisher","unstructured":"Nguyen TT, Shin DH, Sohoni S, Singh SK, Rivera-Molina Y, Jiang H, et al. Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. J Immunother Cancer. 2022;10. https:\/\/doi.org\/10.1136\/jitc-2022-004935.","DOI":"10.1136\/jitc-2022-004935"},{"key":"2164_CR203","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202107461","volume":"18","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang K, Wu Y, Yue Y, Cheng K, Feng Q, et al. Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-photothermal therapy. Small. 2022;18: e2107461. https:\/\/doi.org\/10.1002\/smll.202107461.","journal-title":"Small"},{"key":"2164_CR204","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1002\/ijc.31417","volume":"143","author":"X Liu","year":"2018","unstructured":"Liu X, Zhou W, Zhang X, Ding Y, Du Q, Hu R. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells. Int J Cancer. 2018;143:1516\u201329. https:\/\/doi.org\/10.1002\/ijc.31417.","journal-title":"Int J Cancer"},{"key":"2164_CR205","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/08830185.2021.1954638","volume":"41","author":"M Ala","year":"2022","unstructured":"Ala M. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system. Int Rev Immunol. 2022;41:326\u201345. https:\/\/doi.org\/10.1080\/08830185.2021.1954638.","journal-title":"Int Rev Immunol"},{"key":"2164_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/srep10466","volume":"5","author":"H Jin","year":"2015","unstructured":"Jin H, Zhang Y, You H, Tao X, Wang C, Jin G, et al. Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma. Sci Rep. 2015;5: 10466. https:\/\/doi.org\/10.1038\/srep10466.","journal-title":"Sci Rep"},{"key":"2164_CR207","doi-asserted-by":"publisher","unstructured":"Li B, Jiang Y, Li G, Fisher GA Jr., Li R. Natural killer cell and stroma abundance are independently prognostic and predict gastric cancer chemotherapy benefit. JCI Insight. 2020;5. https:\/\/doi.org\/10.1172\/jci.insight.136570.","DOI":"10.1172\/jci.insight.136570"},{"key":"2164_CR208","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2015.1069936","volume":"5","author":"T Li","year":"2016","unstructured":"Li T, Zhang Q, Jiang Y, Yu J, Hu Y, Mou T, et al. Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2. Oncoimmunology. 2016;5: e1069936. https:\/\/doi.org\/10.1080\/2162402x.2015.1069936.","journal-title":"Oncoimmunology"},{"key":"2164_CR209","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","volume":"22","author":"TJ Laskowski","year":"2022","unstructured":"Laskowski TJ, Biederst\u00e4dt A, Rezvani K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer. 2022;22:557\u201375. https:\/\/doi.org\/10.1038\/s41568-022-00491-0.","journal-title":"Nat Rev Cancer"},{"key":"2164_CR210","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2018.09.007","volume":"175","author":"S Su","year":"2018","unstructured":"Su S, Zhao J, Xing Y, Zhang X, Liu J, Ouyang Q, et al. Immune checkpoint inhibition overcomes ADCP-induced immunosuppression by macrophages. Cell. 2018;175:442\u201357. https:\/\/doi.org\/10.1016\/j.cell.2018.09.007.","journal-title":"Cell"},{"key":"2164_CR211","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24065812","volume":"24","author":"B Kapro\u0144","year":"2023","unstructured":"Kapro\u0144 B, Czarnomysy R, Radomska D, Bielawski K, Plech T. Thiosemicarbazide derivatives targeting human TopoII\u03b1 and IDO-1 as small-molecule drug candidates for breast cancer treatment. Int J Mol Sci. 2023;24:24. https:\/\/doi.org\/10.3390\/ijms24065812.","journal-title":"Int J Mol Sci."},{"key":"2164_CR212","doi-asserted-by":"publisher","first-page":"102717","DOI":"10.1016\/j.ebiom.2020.102717","volume":"54","author":"TT Huang","year":"2020","unstructured":"Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, et al. Kynurenine 3-monooxygenase upregulates pluripotent genes through \u03b2-catenin and promotes triple-negative breast cancer progression. EBioMedicine. 2020;54:102717. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102717.","journal-title":"EBioMedicine"},{"key":"2164_CR213","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","volume":"590","author":"O Bartok","year":"2021","unstructured":"Bartok O, Pataskar A, Nagel R, Laos M, Goldfarb E, Hayoun D, et al. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature. 2021;590:332\u20137. https:\/\/doi.org\/10.1038\/s41586-020-03054-1.","journal-title":"Nature"},{"key":"2164_CR214","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.911019","volume":"13","author":"M Cecchi","year":"2022","unstructured":"Cecchi M, Mannini A, Lapucci A, Silvano A, Lulli M, Luceri C, et al. Dexamethasone promotes a stem-like phenotype in human melanoma cells via tryptophan 2,3 dioxygenase. Front Pharmacol. 2022;13: 911019. https:\/\/doi.org\/10.3389\/fphar.2022.911019.","journal-title":"Front Pharmacol"},{"key":"2164_CR215","doi-asserted-by":"publisher","unstructured":"Balakrishna P, George S, Hatoum H, Mukherjee S. Serotonin Pathway in Cancer. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/ijms22031268.","DOI":"10.3390\/ijms22031268"},{"key":"2164_CR216","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.7150\/thno.55986","volume":"11","author":"S Karmakar","year":"2021","unstructured":"Karmakar S, Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics. 2021;11:5296\u2013312. https:\/\/doi.org\/10.7150\/thno.55986.","journal-title":"Theranostics"},{"key":"2164_CR217","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tem.2020.04.008","volume":"31","author":"V Kannen","year":"2020","unstructured":"Kannen V, Bader M, Sakita JY, Uyemura SA, Squire JA. The dual role of serotonin in colorectal cancer. Trends Endocrinol Metab. 2020;31:611\u201325. https:\/\/doi.org\/10.1016\/j.tem.2020.04.008.","journal-title":"Trends Endocrinol Metab"},{"key":"2164_CR218","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.drup.2014.09.001","volume":"17","author":"MA Peters","year":"2014","unstructured":"Peters MA, Walenkamp AM, Kema IP, Meijer C, de Vries EG, Oosting SF. Dopamine and serotonin regulate tumor behavior by affecting angiogenesis. Drug Resist Updat. 2014;17:96\u2013104. https:\/\/doi.org\/10.1016\/j.drup.2014.09.001.","journal-title":"Drug Resist Updat"},{"key":"2164_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188618","volume":"1876","author":"D Ye","year":"2021","unstructured":"Ye D, Xu H, Tang Q, Xia H, Zhang C, Bi F. The role of 5-HT metabolism in cancer. Biochim Biophys Acta Rev Cancer. 2021;1876: 188618. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188618.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2164_CR220","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.923307","volume":"12","author":"C Ge","year":"2022","unstructured":"Ge C, Yan J, Yuan X, Xu G. A positive feedback loop between tryptophan hydroxylase 1 and \u03b2-Catenin\/ZBP-89 signaling promotes prostate cancer progression. Front Oncol. 2022;12: 923307. https:\/\/doi.org\/10.3389\/fonc.2022.923307.","journal-title":"Front Oncol"},{"key":"2164_CR221","doi-asserted-by":"publisher","first-page":"25975","DOI":"10.18632\/oncotarget.4543","volume":"6","author":"H Sui","year":"2015","unstructured":"Sui H, Xu H, Ji Q, Liu X, Zhou L, Song H, et al. 5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1\/\u03b2-catenin\/MMP-7 signaling pathway. Oncotarget. 2015;6:25975\u201387. https:\/\/doi.org\/10.18632\/oncotarget.4543.","journal-title":"Oncotarget"},{"key":"2164_CR222","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41416-019-0640-1","volume":"122","author":"M Sola-Penna","year":"2020","unstructured":"Sola-Penna M, Paix\u00e3o LP, Branco JR, Ochioni AC, Albanese JM, Mundim DM, et al. Serotonin activates glycolysis and mitochondria biogenesis in human breast cancer cells through activation of the Jak1\/STAT3\/ERK1\/2 and adenylate cyclase\/PKA, respectively. Br J Cancer. 2020;122:194\u2013208. https:\/\/doi.org\/10.1038\/s41416-019-0640-1.","journal-title":"Br J Cancer"},{"key":"2164_CR223","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.bbrc.2006.03.080","volume":"343","author":"B Sonier","year":"2006","unstructured":"Sonier B, Arseneault M, Lavigne C, Ouellette RJ, Vaillancourt C. The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun. 2006;343:1053\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2006.03.080.","journal-title":"Biochem Biophys Res Commun"},{"key":"2164_CR224","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23:716\u201324. https:\/\/doi.org\/10.1016\/j.chom.2018.05.003.","journal-title":"Cell Host Microbe"},{"key":"2164_CR225","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00013","volume":"8","author":"J Gao","year":"2018","unstructured":"Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, et al. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front Cell Infect Microbiol. 2018;8: 13. https:\/\/doi.org\/10.3389\/fcimb.2018.00013.","journal-title":"Front Cell Infect Microbiol"},{"key":"2164_CR226","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111691","volume":"183","author":"Y Wan","year":"2019","unstructured":"Wan Y, Li Y, Yan C, Yan M, Tang Z, Indole. A privileged scaffold for the design of anti-cancer agents. Eur J Med Chem. 2019;183: 111691. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111691.","journal-title":"Eur J Med Chem"},{"key":"2164_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2023.127392","volume":"272","author":"Y Liu","year":"2023","unstructured":"Liu Y, Pei Z, Pan T, Wang H, Chen W, Lu W. Indole metabolites and colorectal cancer: Gut microbial tryptophan metabolism, host gut microbiome biomarkers, and potential intervention mechanisms. Microbiol Res. 2023;272: 127392. https:\/\/doi.org\/10.1016\/j.micres.2023.127392.","journal-title":"Microbiol Res"},{"key":"2164_CR228","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7\u201314. https:\/\/doi.org\/10.1016\/j.coi.2020.12.001.","journal-title":"Curr Opin Immunol"},{"key":"2164_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624324","volume":"12","author":"M Nachef","year":"2021","unstructured":"Nachef M, Ali AK, Almutairi SM, Lee SH. Targeting SLC1A5 and SLC3A2\/SLC7A5 as a potential strategy to strengthen anti-tumor immunity in the tumor microenvironment. Front Immunol. 2021;12: 624324. https:\/\/doi.org\/10.3389\/fimmu.2021.624324.","journal-title":"Front Immunol"},{"key":"2164_CR230","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1183\/13993003.00062-2022","volume":"60","author":"X Liu","year":"2022","unstructured":"Liu X, Qin H, Li Z, Lv Y, Feng S, Zhuang W, et al. Inspiratory hyperoxia suppresses lung cancer metastasis through a MYC\/SLC1A5-dependent metabolic pathway. Eur Respir J. 2022;60:60. https:\/\/doi.org\/10.1183\/13993003.00062-2022.","journal-title":"Eur Respir J."},{"key":"2164_CR231","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1182\/blood.2021013201","volume":"139","author":"ML Amaya","year":"2022","unstructured":"Amaya ML, Inguva A, Pei S, Jones C, Krug A, Ye H, et al. The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation. Blood. 2022;139:584\u201396. https:\/\/doi.org\/10.1182\/blood.2021013201.","journal-title":"Blood"},{"key":"2164_CR232","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2022;230: 107964. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107964.","journal-title":"Pharmacol Ther"},{"key":"2164_CR233","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/10408398.2019.1598334","volume":"60","author":"M Sun","year":"2020","unstructured":"Sun M, Ma N, He T, Johnston LJ, Ma X. Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR). Crit Rev Food Sci Nutr. 2020;60:1760\u20138. https:\/\/doi.org\/10.1080\/10408398.2019.1598334.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2164_CR234","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"A Sadik","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, et al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell. 2020;182:1252\u201370.e34.","journal-title":"Cell"},{"key":"2164_CR235","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1038\/s41467-023-41218-5","volume":"14","author":"Z Ma","year":"2023","unstructured":"Ma Z, Li Z, Mao Y, Ye J, Liu Z, Wang Y, et al. AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer. Nat Commun. 2023;14:5415. https:\/\/doi.org\/10.1038\/s41467-023-41218-5.","journal-title":"Nat Commun"},{"key":"2164_CR236","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, Pieraccini G, et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372\u201385. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.003.","journal-title":"Immunity"},{"key":"2164_CR237","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","volume":"72","author":"RF Schwabe","year":"2020","unstructured":"Schwabe RF, Greten TF. Gut microbiome in HCC - Mechanisms, diagnosis and therapy. J Hepatol. 2020;72:230\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.016.","journal-title":"J Hepatol"},{"key":"2164_CR238","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/cmi.2017.143","volume":"15","author":"L Zhai","year":"2018","unstructured":"Zhai L, Ladomersky E, Lenzen A, Nguyen B, Patel R, Lauing KL, et al. IDO1 in cancer: a Gemini of immune checkpoints. Cell Mol Immunol. 2018;15:447\u201357. https:\/\/doi.org\/10.1038\/cmi.2017.143.","journal-title":"Cell Mol Immunol"},{"key":"2164_CR239","doi-asserted-by":"publisher","unstructured":"Tr\u00e9z\u00e9guet V, Fatrouni H, Merched AJ. Immuno-Metabolic Modulation of Liver Oncogenesis by the Tryptophan Metabolism. Cells. 2021;10. https:\/\/doi.org\/10.3390\/cells10123469.","DOI":"10.3390\/cells10123469"},{"key":"2164_CR240","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/1078-0432.Ccr-18-2882","volume":"25","author":"BW Labadie","year":"2019","unstructured":"Labadie BW, Bao R, Luke JJ. Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the Tryptophan-Kynurenine-Aryl hydrocarbon axis. Clin Cancer Res. 2019;25:1462\u201371. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2882.","journal-title":"Clin Cancer Res"},{"key":"2164_CR241","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35:1304\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004.","journal-title":"Cell Metab"},{"key":"2164_CR242","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1002\/jcp.30876","volume":"237","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang J, Yang Y, Xiang K, Li H, Sun D, et al. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression. J Cell Physiol. 2022;237:4339\u201355. https:\/\/doi.org\/10.1002\/jcp.30876.","journal-title":"J Cell Physiol"},{"key":"2164_CR243","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/molecules27010273","volume":"27","author":"TD Hughes","year":"2022","unstructured":"Hughes TD, G\u00fcner OF, Iradukunda EC, Phillips RS, Bowen JP. The kynurenine pathway and kynurenine 3-monooxygenase inhibitors. Molecules. 2022;27:27. https:\/\/doi.org\/10.3390\/molecules27010273.","journal-title":"Molecules."},{"key":"2164_CR244","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3171\/2015.5.Jns141901","volume":"124","author":"M Hanihara","year":"2016","unstructured":"Hanihara M, Kawataki T, Oh-Oka K, Mitsuka K, Nakao A, Kinouchi H. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model. J Neurosurg. 2016;124:1594\u2013601. https:\/\/doi.org\/10.3171\/2015.5.Jns141901.","journal-title":"J Neurosurg"},{"key":"2164_CR245","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/neuonc\/noad174","volume":"26","author":"TS Johnson","year":"2024","unstructured":"Johnson TS, MacDonald TJ, Pacholczyk R, Aguilera D, Al-Basheer A, Bajaj M, et al. Indoximod-based chemo-immunotherapy for pediatric brain tumors: a first-in-children phase I trial. Neuro Oncol. 2024;26:348\u201361. https:\/\/doi.org\/10.1093\/neuonc\/noad174.","journal-title":"Neuro Oncol"},{"key":"2164_CR246","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1158\/0008-5472.Can-17-0468","volume":"77","author":"H Jiang","year":"2017","unstructured":"Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, et al. Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination. Cancer Res. 2017;77:3894\u2013907. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-0468.","journal-title":"Cancer Res"},{"key":"2164_CR247","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.947872","volume":"3","author":"H Jiang","year":"2014","unstructured":"Jiang H, Fueyo J. Healing after death: antitumor immunity induced by oncolytic adenoviral therapy. Oncoimmunology. 2014;3: e947872. https:\/\/doi.org\/10.4161\/21624011.2014.947872.","journal-title":"Oncoimmunology"},{"key":"2164_CR248","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1285113","volume":"14","author":"M Hu","year":"2023","unstructured":"Hu M, Liao X, Tao Y, Chen Y. Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma. Front Immunol. 2023;14: 1285113. https:\/\/doi.org\/10.3389\/fimmu.2023.1285113.","journal-title":"Front Immunol"},{"key":"2164_CR249","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/v15081645","volume":"15","author":"P Muthukutty","year":"2023","unstructured":"Muthukutty P, Yoo SY. Oncolytic virus engineering and utilizations: cancer immunotherapy perspective. Viruses. 2023;15:15. https:\/\/doi.org\/10.3390\/v15081645.","journal-title":"Viruses."},{"key":"2164_CR250","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cancers15123157","volume":"15","author":"T Dong","year":"2023","unstructured":"Dong T, Shah JR, Phung AT, Larson C, Sanchez AB, Aisagbonhi O, et al. A local and abscopal effect observed with liposomal encapsulation of intratumorally injected oncolytic adenoviral therapy. Cancers (Basel). 2023;15:15. https:\/\/doi.org\/10.3390\/cancers15123157.","journal-title":"Cancers (Basel)"},{"key":"2164_CR251","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/jco.2017.75.8219","volume":"36","author":"FF Lang","year":"2018","unstructured":"Lang FF, Conrad C, Gomez-Manzano C, Yung WKA, Sawaya R, Weinberg JS, et al. Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: replication and immunotherapeutic effects in recurrent malignant glioma. J Clin Oncol. 2018;36:1419\u201327. https:\/\/doi.org\/10.1200\/jco.2017.75.8219.","journal-title":"J Clin Oncol"},{"key":"2164_CR252","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/glia.22734","volume":"63","author":"M Ott","year":"2015","unstructured":"Ott M, Litzenburger UM, Rauschenbach KJ, Bunse L, Ochs K, Sahm F, et al. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia. 2015;63:78\u201390. https:\/\/doi.org\/10.1002\/glia.22734.","journal-title":"Glia"},{"key":"2164_CR253","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcis.2019.04.022","volume":"548","author":"J Liu","year":"2019","unstructured":"Liu J, Zheng J, Nie H, Zhang D, Cao D, Xing Z, et al. Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy. J Colloid Interface Sci. 2019;548:131\u201344. https:\/\/doi.org\/10.1016\/j.jcis.2019.04.022.","journal-title":"J Colloid Interface Sci"},{"key":"2164_CR254","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2020.1809947","volume":"9","author":"C Wang","year":"2020","unstructured":"Wang C, Yan J, Yin P, Gui L, Ji L, Ma B, et al. \u03b2-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancer. Oncoimmunology. 2020;9: 1809947. https:\/\/doi.org\/10.1080\/2162402x.2020.1809947.","journal-title":"Oncoimmunology"},{"key":"2164_CR255","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jconrel.2020.06.032","volume":"325","author":"D Zhi","year":"2020","unstructured":"Zhi D, Yang T, O\u2019Hagan J, Zhang S, Donnelly RF. Photothermal therapy. J Control Release. 2020;325:52\u201371. https:\/\/doi.org\/10.1016\/j.jconrel.2020.06.032.","journal-title":"J Control Release"},{"key":"2164_CR256","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13193","volume":"7","author":"Q Chen","year":"2016","unstructured":"Chen Q, Xu L, Liang C, Wang C, Peng R, Liu Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7: 13193. https:\/\/doi.org\/10.1038\/ncomms13193.","journal-title":"Nat Commun"},{"key":"2164_CR257","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1021\/acsnano.7b00715","volume":"11","author":"J Xu","year":"2017","unstructured":"Xu J, Xu L, Wang C, Yang R, Zhuang Q, Han X, et al. Near-infrared-triggered photodynamic therapy with multitasking upconversion nanoparticles in combination with checkpoint blockade for immunotherapy of colorectal cancer. ACS Nano. 2017;11:4463\u201374. https:\/\/doi.org\/10.1021\/acsnano.7b00715.","journal-title":"ACS Nano"},{"key":"2164_CR258","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201802228","volume":"31","author":"Q Chen","year":"2019","unstructured":"Chen Q, Chen J, Yang Z, Xu J, Xu L, Liang C, et al. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy. Adv Mater. 2019;31:e1802228. https:\/\/doi.org\/10.1002\/adma.201802228.","journal-title":"Adv Mater"},{"key":"2164_CR259","doi-asserted-by":"publisher","first-page":"20342","DOI":"10.1021\/acsami.8b05876","volume":"10","author":"R Ge","year":"2018","unstructured":"Ge R, Liu C, Zhang X, Wang W, Li B, Liu J, et al. Photothermal-activatable Fe(3)O(4) Superparticle Nanodrug Carriers with PD-L1 Immune Checkpoint Blockade for Anti-metastatic Cancer Immunotherapy. ACS Appl Mater Interfaces. 2018;10:20342\u201355. https:\/\/doi.org\/10.1021\/acsami.8b05876.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2164_CR260","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1158\/0008-5472.Can-19-3074","volume":"80","author":"L Ji","year":"2020","unstructured":"Ji L, Qian W, Gui L, Ji Z, Yin P, Lin GN, et al. Blockade of \u03b2-Catenin-Induced CCL28 Suppresses Gastric Cancer Progression via Inhibition of Treg Cell Infiltration. Cancer Res. 2020;80:2004\u201316. https:\/\/doi.org\/10.1158\/0008-5472.Can-19-3074.","journal-title":"Cancer Res"},{"key":"2164_CR261","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nbt.4180","volume":"36","author":"TA Triplett","year":"2018","unstructured":"Triplett TA, Garrison KC, Marshall N, Donkor M, Blazeck J, Lamb C, et al. Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme. Nat Biotechnol. 2018;36:758\u201364. https:\/\/doi.org\/10.1038\/nbt.4180.","journal-title":"Nat Biotechnol"},{"key":"2164_CR262","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00262-020-02697-3","volume":"70","author":"Q Liu","year":"2021","unstructured":"Liu Q, Hua S, Wang X, Chen F, Gou S. The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma. Cancer Immunol Immunother. 2021;70:497\u2013508. https:\/\/doi.org\/10.1007\/s00262-020-02697-3.","journal-title":"Cancer Immunol Immunother"},{"key":"2164_CR263","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100947","volume":"68","author":"R Du","year":"2023","unstructured":"Du R, Zhang X, Lu X, Ma X, Guo X, Shi C, et al. PDPN positive CAFs contribute to HER2 positive breast cancer resistance to trastuzumab by inhibiting antibody-dependent NK cell-mediated cytotoxicity. Drug Resist Updat. 2023;68: 100947. https:\/\/doi.org\/10.1016\/j.drup.2023.100947.","journal-title":"Drug Resist Updat"},{"key":"2164_CR264","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bcp.2019.07.011","volume":"168","author":"X Feng","year":"2019","unstructured":"Feng X, Shen P, Wang Y, Li Z, Bian J. Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1\/IDO2\/TDO. Biochem Pharmacol. 2019;168:214\u201323. https:\/\/doi.org\/10.1016\/j.bcp.2019.07.011.","journal-title":"Biochem Pharmacol"},{"key":"2164_CR265","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/s41591-021-01544-x","volume":"27","author":"JW Kjeldsen","year":"2021","unstructured":"Kjeldsen JW, Lorentzen CL, Martinenaite E, Ellebaek E, Donia M, Holmstroem RB, et al. A phase 1\/2 trial of an immune-modulatory vaccine against IDO\/PD-L1 in combination with nivolumab in metastatic melanoma. Nat Med. 2021;27:2212\u201323. https:\/\/doi.org\/10.1038\/s41591-021-01544-x.","journal-title":"Nat Med"},{"key":"2164_CR266","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/s1470-2045(19)30274-8","volume":"20","author":"GV Long","year":"2019","unstructured":"Long GV, Dummer R, Hamid O, Gajewski TF, Caglevic C, Dalle S, et al. Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study. Lancet Oncol. 2019;20:1083\u201397. https:\/\/doi.org\/10.1016\/s1470-2045(19)30274-8.","journal-title":"Lancet Oncol"},{"key":"2164_CR267","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng CH, Gigoux M, Cohen IJ, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun. 2020;11:4011. https:\/\/doi.org\/10.1038\/s41467-020-17750-z.","journal-title":"Nat Commun"},{"key":"2164_CR268","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1038\/s41467-024-47868-3","volume":"15","author":"N Venkateswaran","year":"2024","unstructured":"Venkateswaran N, Garcia R, Lafita-Navarro MC, Hao YH, Perez-Castro L, Nogueira PAS, et al. Tryptophan fuels MYC-dependent liver tumorigenesis through indole 3-pyruvate synthesis. Nat Commun. 2024;15:4266. https:\/\/doi.org\/10.1038\/s41467-024-47868-3.","journal-title":"Nat Commun"},{"key":"2164_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102461","volume":"110","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, et al. Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat Rev. 2022;110: 102461. https:\/\/doi.org\/10.1016\/j.ctrv.2022.102461.","journal-title":"Cancer Treat Rev"},{"key":"2164_CR270","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00277","volume":"9","author":"G Zhang","year":"2018","unstructured":"Zhang G, Xing J, Wang Y, Wang L, Ye Y, Lu D, et al. Discovery of novel inhibitors of indoleamine 2,3-Dioxygenase 1 through structure-based virtual screening. Front Pharmacol. 2018;9: 277. https:\/\/doi.org\/10.3389\/fphar.2018.00277.","journal-title":"Front Pharmacol"},{"key":"2164_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111750","volume":"184","author":"Y Zou","year":"2019","unstructured":"Zou Y, Hu Y, Ge S, Zheng Y, Li Y, Liu W, et al. Effective virtual screening strategy toward heme-containing proteins: identification of novel IDO1 inhibitors. Eur J Med Chem. 2019;184: 111750. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111750.","journal-title":"Eur J Med Chem"},{"key":"2164_CR272","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/17460441.2020.1781811","volume":"15","author":"L Sun","year":"2020","unstructured":"Sun L. Advances in the discovery and development of selective heme-displacing IDO1 inhibitors. Expert Opin Drug Discov. 2020;15:1223\u201332. https:\/\/doi.org\/10.1080\/17460441.2020.1781811.","journal-title":"Expert Opin Drug Discov"},{"key":"2164_CR273","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1001956","volume":"13","author":"J Ogbechi","year":"2022","unstructured":"Ogbechi J, Huang YS, Clanchy FIL, Pantazi E, Topping LM, Darlington LG, et al. Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS). Front Immunol. 2022;13: 1001956. https:\/\/doi.org\/10.3389\/fimmu.2022.1001956.","journal-title":"Front Immunol"},{"key":"2164_CR274","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","volume":"41","author":"AJ Muller","year":"2019","unstructured":"Muller AJ, Manfredi MG, Zakharia Y, Prendergast GC. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond. Semin Immunopathol. 2019;41:41\u20138. https:\/\/doi.org\/10.1007\/s00281-018-0702-0.","journal-title":"Semin Immunopathol"},{"key":"2164_CR275","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ejmech.2017.11.088","volume":"143","author":"T Weng","year":"2018","unstructured":"Weng T, Qiu X, Wang J, Li Z, Bian J. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy. Eur J Med Chem. 2018;143:656\u201369. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.088.","journal-title":"Eur J Med Chem"},{"key":"2164_CR276","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.725204","volume":"12","author":"C Yang","year":"2021","unstructured":"Yang C, Ng CT, Li D, Zhang L. Targeting indoleamine 2,3-Dioxygenase 1: Fighting cancers via dormancy regulation. Front Immunol. 2021;12: 725204. https:\/\/doi.org\/10.3389\/fimmu.2021.725204.","journal-title":"Front Immunol"},{"key":"2164_CR277","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/14756366.2020.1765165","volume":"35","author":"S Ge","year":"2020","unstructured":"Ge S, Zhong H, Ma X, Zheng Y, Zou Y, Wang F, et al. Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo. J Enzyme Inhib Med Chem. 2020;35:1240\u201357. https:\/\/doi.org\/10.1080\/14756366.2020.1765165.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"2164_CR278","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biochi.2021.01.005","volume":"182","author":"XH Liu","year":"2021","unstructured":"Liu XH, Zhai XY. Role of tryptophan metabolism in cancers and therapeutic implications. Biochimie. 2021;182:131\u20139. https:\/\/doi.org\/10.1016\/j.biochi.2021.01.005.","journal-title":"Biochimie"},{"key":"2164_CR279","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ccell.2014.10.002","volume":"26","author":"KS Tummala","year":"2014","unstructured":"Tummala KS, Gomes AL, Yilmaz M, Gra\u00f1a O, Bakiri L, Ruppen I, et al. Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell. 2014;26:826\u201339. https:\/\/doi.org\/10.1016\/j.ccell.2014.10.002.","journal-title":"Cancer Cell"},{"key":"2164_CR280","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3389\/fimmu.2019.01801","volume":"10","author":"J G\u00fcnther","year":"2019","unstructured":"G\u00fcnther J, D\u00e4britz J, Wirthgen E. Limitations and off-target effects of tryptophan-related ido inhibitors in cancer treatment. Front Immunol. 2019;10:1801. https:\/\/doi.org\/10.3389\/fimmu.2019.01801.","journal-title":"Front Immunol"},{"key":"2164_CR281","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.2147\/dddt.S373780","volume":"16","author":"X Peng","year":"2022","unstructured":"Peng X, Zhao Z, Liu L, Bai L, Tong R, Yang H, et al. Targeting indoleamine dioxygenase and tryptophan dioxygenase in cancer immunotherapy: clinical progress and challenges. Drug Des Devel Ther. 2022;16:2639\u201357. https:\/\/doi.org\/10.2147\/dddt.S373780.","journal-title":"Drug Des Devel Ther"},{"key":"2164_CR282","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/vco.12641","volume":"19","author":"IL Liu","year":"2021","unstructured":"Liu IL, Chung TF, Huang WH, Hsu CH, Liu CC, Chiu YH, et al. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma. Vet Comp Oncol. 2021;19:79\u201391. https:\/\/doi.org\/10.1111\/vco.12641.","journal-title":"Vet Comp Oncol"},{"key":"2164_CR283","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.620361","volume":"11","author":"CY Liu","year":"2021","unstructured":"Liu CY, Huang TT, Chen JL, Chu PY, Lee CH, Lee HC, et al. Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer. Front Oncol. 2021;11: 620361. https:\/\/doi.org\/10.3389\/fonc.2021.620361.","journal-title":"Front Oncol"},{"key":"2164_CR284","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.21873\/anticanres.16731","volume":"43","author":"LA Sordillo","year":"2023","unstructured":"Sordillo LA, Sordillo PP. Suppression of kynurenine 3-Monooxygenase as a treatment for triple-negative breast carcinoma. Anticancer Res. 2023;43:5275\u201382. https:\/\/doi.org\/10.21873\/anticanres.16731.","journal-title":"Anticancer Res"},{"key":"2164_CR285","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.drudis.2015.11.001","volume":"21","author":"JR Smith","year":"2016","unstructured":"Smith JR, Jamie JF, Guillemin GJ. Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors. Drug Discov Today. 2016;21:315\u201324. https:\/\/doi.org\/10.1016\/j.drudis.2015.11.001.","journal-title":"Drug Discov Today"},{"key":"2164_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108702","volume":"697","author":"S Zhang","year":"2021","unstructured":"Zhang S, Collier MEW, Heyes DJ, Giorgini F, Scrutton NS. Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. Arch Biochem Biophys. 2021;697: 108702. https:\/\/doi.org\/10.1016\/j.abb.2020.108702.","journal-title":"Arch Biochem Biophys"},{"key":"2164_CR287","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14728222.2017.1272581","volume":"21","author":"K Wal\u00f8en","year":"2017","unstructured":"Wal\u00f8en K, Kleppe R, Martinez A, Haavik J. Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease. Expert Opin Ther Targets. 2017;21:167\u201380. https:\/\/doi.org\/10.1080\/14728222.2017.1272581.","journal-title":"Expert Opin Ther Targets"},{"key":"2164_CR288","doi-asserted-by":"publisher","first-page":"11126","DOI":"10.1021\/acs.jmedchem.2c00598","volume":"65","author":"E Specker","year":"2022","unstructured":"Specker E, Matthes S, Wesolowski R, Sch\u00fctz A, Grohmann M, Alenina N, et al. Structure-based design of xanthine-benzimidazole derivatives as novel and potent tryptophan hydroxylase inhibitors. J Med Chem. 2022;65:11126\u201349. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00598.","journal-title":"J Med Chem"},{"key":"2164_CR289","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ecl.2018.04.014","volume":"47","author":"PB Loughrey","year":"2018","unstructured":"Loughrey PB, Zhang D, Heaney AP. New treatments for the carcinoid syndrome. Endocrinol Metab Clin North Am. 2018;47:557\u201376. https:\/\/doi.org\/10.1016\/j.ecl.2018.04.014.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2164_CR290","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.0954-6820.1962.tb04214.x","volume":"171","author":"OO Mustala","year":"1962","unstructured":"Mustala OO, Airaksinen MM. Excretion of histamine and metabolites of 5-hydroxytryptamine in a case of metastasized carcinoid tumour. Acta Med Scand. 1962;171:483\u20139. https:\/\/doi.org\/10.1111\/j.0954-6820.1962.tb04214.x.","journal-title":"Acta Med Scand"},{"key":"2164_CR291","doi-asserted-by":"publisher","DOI":"10.1126\/science.128.3323.537","volume":"128","author":"IW Mc","year":"1958","unstructured":"Mc IW, Page IH. New metabolites of serotonin in carcinoid urine. Science. 1958;128: 537. https:\/\/doi.org\/10.1126\/science.128.3323.537.","journal-title":"Science"},{"key":"2164_CR292","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/febs.16245","volume":"290","author":"L Perez-Castro","year":"2023","unstructured":"Perez-Castro L, Garcia R, Venkateswaran N, Barnes S, Conacci-Sorrell M. Tryptophan and its metabolites in normal physiology and cancer etiology. Febs j. 2023;290:7\u201327. https:\/\/doi.org\/10.1111\/febs.16245.","journal-title":"Febs j"},{"key":"2164_CR293","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/circulationaha.122.059812","volume":"145","author":"GA Wyant","year":"2022","unstructured":"Wyant GA, Moslehi J. Expanding the therapeutic world of tryptophan metabolism. Circulation. 2022;145:1799\u2013802. https:\/\/doi.org\/10.1161\/circulationaha.122.059812.","journal-title":"Circulation"},{"key":"2164_CR294","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121018","volume":"276","author":"Y Guo","year":"2021","unstructured":"Guo Y, Liu Y, Wu W, Ling D, Zhang Q, Zhao P, et al. Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy. Biomaterials. 2021;276: 121018. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121018.","journal-title":"Biomaterials"},{"key":"2164_CR295","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00262-017-2010-2","volume":"66","author":"DH Munn","year":"2017","unstructured":"Munn DH, Sharma MD, Johnson TS, Rodriguez P. IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment. Cancer Immunol Immunother. 2017;66:1049\u201358. https:\/\/doi.org\/10.1007\/s00262-017-2010-2.","journal-title":"Cancer Immunol Immunother"},{"key":"2164_CR296","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.7150\/jca.31727","volume":"10","author":"Z Ye","year":"2019","unstructured":"Ye Z, Yue L, Shi J, Shao M, Wu T. Role of IDO and TDO in Cancers and related diseases and the therapeutic implications. J Cancer. 2019;10:2771\u201382. https:\/\/doi.org\/10.7150\/jca.31727.","journal-title":"J Cancer"},{"key":"2164_CR297","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jitc-2023-007495","volume":"11","author":"C Kober","year":"2023","unstructured":"Kober C, Roewe J, Schmees N, Roese L, Roehn U, Bader B, et al. Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapy. J Immunother Cancer. 2023;11:11. https:\/\/doi.org\/10.1136\/jitc-2023-007495.","journal-title":"J Immunother Cancer."},{"key":"2164_CR298","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40259-018-0291-4","volume":"32","author":"S Yentz","year":"2018","unstructured":"Yentz S, Smith D. Indoleamine 2,3-Dioxygenase (IDO) inhibition as a strategy to augment cancer immunotherapy. BioDrugs. 2018;32:311\u20137. https:\/\/doi.org\/10.1007\/s40259-018-0291-4.","journal-title":"BioDrugs"},{"key":"2164_CR299","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2174\/1568009615666151030102250","volume":"16","author":"SR Selvan","year":"2016","unstructured":"Selvan SR, Dowling JP, Kelly WK, Lin J. Indoleamine 2,3-dioxygenase (IDO): biology and target in cancer immunotherapies. Curr Cancer Drug Targets. 2016;16:755\u201364. https:\/\/doi.org\/10.2174\/1568009615666151030102250.","journal-title":"Curr Cancer Drug Targets"},{"key":"2164_CR300","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells12101433","volume":"12","author":"SY Kado","year":"2023","unstructured":"Kado SY, Bein K, Castaneda AR, Pouraryan AA, Garrity N, Ishihara Y, et al. Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in breast cancer. Cells. 2023;12:12. https:\/\/doi.org\/10.3390\/cells12101433.","journal-title":"Cells."},{"key":"2164_CR301","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/1573412918666211213142638","volume":"18","author":"B Seyfinejad","year":"2022","unstructured":"Seyfinejad B, Jouyban A. Importance of method validation in the analysis of biomarker. Curr Pharm Anal. 2022;18:567\u20139. https:\/\/doi.org\/10.2174\/1573412918666211213142638.","journal-title":"Curr Pharm Anal"},{"key":"2164_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100675","volume":"20","author":"D Xiang","year":"2023","unstructured":"Xiang D, Han X, Li J, Zhang J, Xiao H, Li T, et al. Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma. Mater Today Bio. 2023;20: 100675. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100675.","journal-title":"Mater Today Bio"},{"key":"2164_CR303","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1016\/j.cub.2023.05.066","volume":"33","author":"N Ahuja","year":"2023","unstructured":"Ahuja N, Hwaun E, Pungor JR, Rafiq R, Nemes S, Sakmar T, et al. Creation of an albino squid line by CRISPR-Cas9 and its application for in vivo functional imaging of neural activity. Curr Biol. 2023;33:2774\u2013e2835. https:\/\/doi.org\/10.1016\/j.cub.2023.05.066.","journal-title":"Curr Biol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02164-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T09:28:56Z","timestamp":1730280536000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":303,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02164-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The corresponding author has received consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}